Scalable syntheses of nicotinoyl ribosides and reduced nic otinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
A scalable synthetic process using liquid-assisted mixing and mechanochemistry addresses inefficiencies in nicotinoyl riboside synthesis, enhancing production efficiency and stability, and facilitating broader availability for health applications.
Patent Information
- Application Number
- CA3045876
- Authority / Receiving Office
- CA · CA
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-11-10
- Filing Date
- 2017-11-10
- Publication Date
- 2026-11-03
- Estimated Expiration
- 2037-11-10
AI Technical Summary
Current methods for synthesizing nicotinoyl ribosides, reduced nicotinoyl ribosides, and their derivatives face challenges such as low yields, product instability, batch-to-batch variation, and inefficiencies due to the use of corrosive and expensive reagents, along with difficulties in controlling phosphorylation reactions and forming pyrophosphate bonds at scale.
A scalable synthetic process utilizing liquid-assisted mixing, grinding, milling, and/or extrusion to produce nicotinoyl ribosides and their derivatives, minimizing solvent use and optimizing reaction times, while employing mechanochemistry and continuous liquid-liquid extraction for efficient production.
This process enables the production of nicotinoyl ribosides and derivatives with improved stability and reduced solvent use, achieving higher yields and consistent quality, making these compounds more widely available for nutraceutical and pharmaceutical applications.
Abstract
Description
DEMANDE OU BREVET VOLUMINEUX LA PRÉSENTE PARTIE DE CETTE DEMANDE OU CE BREVET COMPREND PLUS D'UN TOME. CECI EST LE TOME 1 DE 3 CONTENANT LES PAGES 1 À 187 NOTE: Pour les tomes additionels, veuillez contacter le Bureau canadien des brevets JUMBO APPLICATIONS / PATENTS THIS SECTION OF THE APPLICATION / PATENT CONTAINS MORE THAN ONE VOLUME THIS IS VOLUME 1 OF 3 CONTAINING PAGES 1 TO 187 NOTE: For additional volumes, please contact the Canadian Patent Office NOM DU FICHIER / FILE NAME : NOTE POUR LE TOME / VOLUME NOTE: SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF TECHNICAL FIELD
[0001] The present disclosure relates to synthetic processes for the preparation of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, the synthetic processes comprising processing of reagents by solvent-based processes, liquid-assisted mixing, milling, grinding, solvent-assisted grinding, and / or extrusion, and crystalline forms of nicotinamide riboside, in particular, nicotinamide riboside chloride, derivatives thereof, crystalline forms of nicotinic acid riboside, derivatives thereof, and crystalline forms of nicotinamide mononucleotide, and derivatives thereof. BACKGROUND
[0002] The dietary vitamin B3, which encompasses nicotinamide ("Nam" or "NM"), nicotinic acid ("NA"), and nicotinamide riboside ("NR"), is a precursor to the coenzyme nicotinamide adenine dinucleotide ("NAD+"), its phosphorylated parent ("NADP+" or "NAD(P)", and their respective reduced forms ("NADH" and "NADPH," respectively). Once converted intracellularly to NAD(P)<com:Sup>+< / com:Sup> and NAD(P)H, vitamin B3 metabolites are used as co-substrates in multiple intracellular protein modification processes, which control numerous essential signaling events (e.g., adenosine diphosphate ribosylation and deacetylation), and as cofactors in over 400 redox enzymatic reactions, thus controlling metabolism. This is demonstrated by a range of metabolic endpoints, which include the deacylation of key regulatory metabolic enzymes, resulting in the restoration of mitochondrial activity and oxygen consumption. Critically, mitochondrial dysfunction and cellular impairment have been correlated to the depletion of the NAD(P)(H)-cofactor pool, when the NAD(P)(H)-cofactor pool is present in sub-optimal intracellular concentrations. Vitamin B3 deficiency yields to evidenced compromised cellular activity through NAD(P)<com:Sup>+< / com:Sup> depletion, and the beneficial effect of additional NAD(P)<com:Sup>+< / com:Sup> bioavailability through NA, Nam, NR, and nicotinamide mononucleotide ("NMN") supplementation is primarily observed in cells and tissues where metabolism and mitochondrial function have been compromised.
[0003] Despite extensive optimization of solution-based methodologies over many years for nucleotide preparation, difficulties and issues remain in the syntheses of nicotinoyl ribosides, the monophosphorylation of active hydroxyl groups thereof, and subsequent conjugation thereof, with respect to low yields and product stability and isolation from polar solvents. The current methodologies are also plagued by atom and energy inefficiency due, for example, to the use of large solvent excesses and the need for temperature-controlled reaction conditions.
[0004] The reported syntheses of nicotinamide riboside (NR) are becoming more scalable, but use corrosive and expensive reagents, and lengthy deprotection steps, and thus still display batch-to-batch quality variation, thereby presenting difficulties in maintaining good standards.
[0005] Partially protected nucleosides and nucleotides have found broad-ranging application in order to achieve improved bioavailability of the nucleoside and nucleotide parents. Such partial protection includes hydroxyl modifications with ester, carboxylate, and acetyl groups, in addition to the introduction of hydrolyzable phosphoramidate or mixed anhydride modification of the phosphate monoesters in the form of Protides and CycloSal derivatives. While the former type of protection has become more scalable, the modifications at the phosphorus center remain difficult to accomplish at scale, particularly on nucleosidic entities that are highly sensitive to changes in pH and that are readily degraded by heat.
[0006] Reduced nicotinamide riboside ("NRH") has been consistently shown to be more efficient at increasing intracellular NAD<com:Sup>+< / com:Sup> levels, and surpasses nicotinamide riboside (NR) in that respect. While physiological and potentially therapeutic roles have not yet been examined due to a lack of material accessible in sufficient quantities for broad-ranging studies, it is anticipated that the phosphorylated forms of NRH and reduced nicotinic acid riboside ("NARH"), or derivatives thereof, could also have similar NAD+-boosting capacities.
[0007] The reported syntheses of reduced nicotinamide riboside (NRH) are becoming more widely available but remain conducted on small scales, using corrosive and expensive reagents, and lengthy deprotection steps, and thus still display batch-to-batch quality variation, thereby presenting difficulties in maintaining good standards. In the current description, reduced nicotinamide riboside (NRH) generally refers to "reduced pyridine" nucleus, more specifically, the 1,4-dihydropyridine compounds.
[0008] Synthetically, the preparation of 5'-nucleotides remains time-consuming, atom- inefficient, and costly, due to the need for numerous protection and deprotection steps. In these preparation methods, the chlorodialkylphosphate, tetraalkylpyrophosphate, chlorophosphite, or phosphoramidite reagents required are also expensive starting materials by virtue of their chemical functionalization and chemical instability, and therefore, consequently associated synthetic difficulties. Phosphorylation reaction conditions are difficult to control and often use non-approved or toxic organic solvents, thus limiting the market of the manufactured compounds.
[0009] One known alternative approach to the protection / deprotection method is to use phosphorus oxychloride (P(O)Cl<com:Sub>3< / com:Sub>) (i.e., Yoshikawa conditions), however there are still drawbacks to this method, as follows. While not being bound by theory, in this method, polar trialkyl phosphate solvents, such as P(O)(OMe)<com:Sub>3< / com:Sub>, are used in a large excess, which are believed to enhance reaction rates while limiting the undesirable reactivity of P(O)Cl<com:Sub>3< / com:Sub> as a chlorinating agent. Thus, it is believed that use of excess P(O)Cl<com:Sub>3< / com:Sub> / P(O)(OR)<com:Sub>3< / com:Sub> is a better combination for the chemoselective 5'-O-phosphorylation of unprotected ribosides. However, the use of trialkyl phosphate solvents, such as P(O)(OMe)<com:Sub>3< / com:Sub>, precludes their implementation for the preparation of materials for eventual human use, as this class of solvent is highly toxic (known carcinogen, non-GRAS approved) and is difficult to remove from the final polar products. See M. Yoshikawa et al., Studies of Phosphorylation. III. Selective Phosphorylation of Unprotected Nucleosides, 42 Bull. Chem. Soc. Japan 3505 (1969); Jaemoon Lee et al., A chemical synthesis of nicotinamide adenine dinucleotide (NAD+), CHEM. COMMUN. 729 (1999).
[0010] Nicotinamide adenine dinucleotide (NAD<com:Sup>+< / com:Sup>) remains an expensive cofactor, and its commercial availability is simply limited by its complex chemical nature and the highly reactive pyrophosphate bond, which is challenging to form at scale.
[0011] Nicotinoyl ribosides such as nicotinamide riboside (NR) and nicotinic acid riboside ("NAR"), nicotinamide mononucleotide (NMN), and NAD<com:Sup>+< / com:Sup> are viewed as useful bioavailable precursors of the NAD(P)(H) pool to combat and treat a broad range of non-communicable diseases, in particular those associated with mitochondrial dysfunction and impaired cellular metabolism. Optimizing the large-scale syntheses of these vitamin B3 derivatives is therefore highly valuable to make these compounds more widely available to society both in terms of nutraceutical and pharmaceutical entities.
[0012] Reduced nicotinoyl ribosides, such as reduced nicotinamide riboside (NRH), reduced nicotinic acid riboside (NARH), reduced nicotinamide mononucleotide ("NMNH"), reduced nicotinic acid mononucleotide ("NaMNH"), and reduced nicotinamide adenine dinucleotide ("NADH") are viewed as useful bioavailable precursors of the NAD(P)(H) pool to combat and treat a broad range of non-communicable diseases, in particular those associated with mitochondrial dysfunction and impaired cellular metabolism. Optimizing the large-scale syntheses of these vitamin B3 derivatives is therefore highly valuable to make these compounds more widely available to society, both in terms of nutraceutical and pharmaceutical entities.
[0013] Crystalline forms of useful molecules can have advantageous properties relative to the respective amorphous forms of such molecules. For example, crystal forms are often easier to handle and process, for example, when preparing compositions that include the crystal forms. Crystalline forms typically have greater storage stability and are more amenable to purification. The use of a crystalline form of a pharmaceutically useful compound can also improve the performance characteristics of a pharmaceutical product that includes the compound. Obtaining the crystalline form also serves to enlarge the repertoire of materials that formulation scientists have available for formulation optimization, for example by providing a product with different properties, e.g., better processing or handling characteristics, improved dissolution profile, or improved shelf-life.
[0014] WO 2016 / 014927 A2, describes crystalline forms of nicotinamide riboside, including a Form I of nicotinamide riboside chloride. Also disclosed are pharmaceutical compositions comprising the crystalline Form I of nicotinamide riboside chloride, and methods of producing such pharmaceutical compositions.
[0015] WO 2016 / 144660 A1, describes crystalline forms of nicotinamide riboside, including a Form II of nicotinamide riboside chloride. Also disclosed are pharmaceutical compositions comprising the crystalline Form II of nicotinamide riboside chloride, and methods of producing such pharmaceutical compositions.
[0016] In view of the above, there is a need for processes that are atom-efficient in terms of reagent and solvent equivalency, that bypass the need for polar, non-GRAS ("generally recognized as safe") solvents, that are versatile in terms of limitations associated with solubility and reagent mixing, that are time- and energy-efficient, and that provide efficient, practical, and scalable methods for the preparation of nicotinoyl ribosides, reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof.
[0017] In view of the above, there is a need for novel crystalline forms of nicotinoyl ribosides, reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof. SUMMARY OF THE INVENTION
[0018] In an embodiment, the present disclosure relates to a synthetic sequence that enables the efficient production of nicotinoyl ribosides, derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof, via processes that are enabled by the processing of reagents by liquid-assisted mixing, grinding, milling, and / or extrusion.
[0019] In another embodiment, the present disclosure relates to a synthetic sequence that enables the efficient production of reduced nicotinoyl ribosides, derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof, via processes that are enabled by the processing of reagents by liquid-assisted mixing, grinding, milling, and / or extrusion.
[0020] In yet another embodiment, the present disclosure relates to scalable methods of preparation of nicotinamide riboside (NR) and nicotinic acid riboside (NAR), and derivatives thereof, or salts, solvates, or prodrugs thereof, by liquid assisted mixing and / or extrusion.
[0021] In yet another embodiment, the present disclosure relates to scalable methods of preparation of reduced nicotinamide riboside (NRH) and reduced nicotinic acid riboside (NARH), and derivatives thereof, or salts, solvates, or prodrugs thereof, by liquid-assisted mixing, grinding, and / or extrusion.
[0022] In yet another embodiment, the present disclosure relates to scalable methods of preparation of nicotinamide riboside triacetate ("NRTA") and nicotinic acid riboside triacetate ("NARTA"), and derivatives thereof, or salts, solvates, or prodrugs thereof, by liquid-assisted mixing, grinding, and / or extrusion.
[0023] In yet another embodiment, the present disclosure relates to scalable methods of preparation of reduced nicotinamide riboside triacetate ("NRH-TA") and reduced nicotinic acid riboside triacetate ("NARH-TA"), and derivatives thereof, or salts, solvates, or prodrugs thereof, by biphasic liquid-assisted mixing, grinding, and / or extrusion.
[0024] In yet another embodiment, the present disclosure relates to batch and semi- continuous processes that enable the production of nicotinamide riboside (NR) and nicotinic acid riboside (NAR), and triacetate derivatives thereof, or salts, solvates, or prodrugs thereof, whereby the use of solvents is kept to a minimum, and whereby conversion and reaction times are optimized by the use of sealed conditions, continuous liquid-liquid extraction, and / or mechanochemistry, and an optimized purification sequence.
[0025] In yet another embodiment, the present disclosure relates to batch and semi- continuous processes that enable the production of reduced nicotinamide riboside (NRH) and reduced nicotinic acid riboside (NARH), and triacetate derivatives thereof, or salts, solvates, or prodrugs thereof, wherein the use of solvents is kept to a minimum, and whereby conversion and reaction times are optimized by the use of sealed conditions, continuous liquid-liquid extraction, and / or mechanochemistry, and an optimized purification sequence.
[0026] In yet another embodiment, the present disclosure relates to crystalline forms of nicotinamide riboside (NR), including, but not limited to, a Form I of nicotinamide riboside chloride ("NR-Cl"), and methods of preparation thereof.
[0027] In yet another embodiment, the present disclosure relates to crystalline forms of nicotinamide riboside (NR), including, but not limited to, a "NR methanolate Form II" of nicotinamide riboside chloride (NR-Cl), and methods of preparation thereof.
[0028] In yet another embodiment, the present disclosure relates to crystalline forms of nicotinic acid riboside (NAR), including, but not limited to, a "Form I" of nicotinic acid riboside (NAR), and methods of preparation thereof.
[0029] In yet another embodiment, the present disclosure relates to crystalline forms of nicotinamide riboside triacetate (1-(2',3',5'-triacetyl-beta-D-ribofuranosyl)-nicotinamide, "NR triacetate," or "NRTA"), including, but not limited to, a "Form I" of nicotinamide riboside triacetate (NRTA) chloride, and methods of preparation thereof.
[0030] In yet another embodiment, the present disclosure relates to crystalline forms of nicotinic acid riboside triacetate (1-(2',3',5'-triacetyl-beta-D-ribofuranosyl)-nicotinic acid, "NAR triacetate," or "NARTA"), including, but not limited to, a "Form I" of nicotinic acid riboside triacetate (NARTA), and methods of preparation thereof.
[0031] In yet another embodiment, the present disclosure relates to crystalline forms of nicotinamide mononucleotide ("NMN"), including, but not limited to, a "Form III" of nicotinamide mononucleotide (NMN), and methods of preparation thereof. In yet another embodiment, the present disclosure relates to an amorphous solid form of nicotinamide mononucleotide (NMN), and methods of preparation thereof.
[0032] In yet another embodiment, the present disclosure relates to crystalline forms of nicotinamide mononucleotide (NMN), including, but not limited to, a "Form IV" of nicotinamide mononucleotide (NMN), and methods of preparation thereof.
[0033] In yet another embodiment, the present disclosure relates to crystalline forms of compounds or derivatives having formula (IV), or salts, solvates, or prodrugs thereof, and methods of preparation thereof.
[0034] In yet another embodiment, the present disclosure relates to crystalline forms of compounds or derivatives having formula (IV-H), or salts, solvates, or prodrugs thereof, and methods of preparation thereof.
[0035] In yet another embodiment, the present disclosure relates to crystalline forms of compounds or derivatives having formula (V), or salts, solvates, or prodrugs thereof, and methods of preparation thereof.
[0036] In yet another embodiment, the present disclosure relates to crystalline forms of compounds or derivatives having formula (VI), or salts, solvates, or prodrugs thereof, and methods of preparation thereof.
[0037] In accordance with one embodiment, the present disclosure provides a novel method for the preparation of compounds or derivatives having formula (I), or salts, solvates, or prodrugs thereof, such as nicotinoyl ribosides and their derivatives, and including but not limited to the triacetylated forms of NR-Cl (nicotinamide riboside chloride salt form) and NAR (nicotinic acid riboside) (compounds or derivatives having formula (I), wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each acetyl groups), and the fully deprotected forms thereof (compounds or derivatives having formula (I), wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen), in commercial quantities. In accordance with such an embodiment, the present disclosure provides a novel method whereby mechanic forces and / or sealed conditions are used to minimize solvent and reagent quantities, decrease reaction times, increase overall conversion, and facilitate product purification in a multistep synthetic sequence, whereby by-product formation is minimized, and whereby primarily by-products that can be removed readily by filtration or evaporation are generated. Prototype product nicotinoyl riboside compounds include compounds or derivatives having formula (I), or salts, solvates, or prodrugs thereof: [Image disponible dans le document PDF, Image available in the PDF document] (I)
[0038] optionally wherein X<com:Sup>-< / com:Sup> as counterion is absent, or when X<com:Sup>-< / com:Sup> is present, X<com:Sup>-< / com:Sup> is selected from the group consisting of fluoride, chloride, bromide, iodide, formate, acetate, propionate, butyrate, glutamate, aspartate, ascorbate, benzoate, carbonate, citrate, carbamate, gluconate, lactate, methyl bromide, methyl sulfate, nitrate, phosphate, diphosphate, succinate, sulfonate, trifluoromethanesulfonate, trichloromethanesulfonate, tribromomethanesulfonate, and trifluoroacetate;
[0039] optionally wherein when X is absent, optionally the counterion is an internal salt;
[0040] <com:Math><semantics>Z1<annotation encoding="application / x-tex">Z^1< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>Z2<annotation encoding="application / x-tex">Z^2< / annotation>< / semantics>< / com:Math> are independently NH or oxygen;
[0041] n is 0 or 1;
[0042] R<com:Sup>1< / com:Sup> is selected from the group consisting of hydrogen, substituted or unsubstituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, and substituted or unsubstituted heterocycle, vitamin B1 ester, vitamin B2 ester, vitamin B6 ester, choline ester, biotin ester, vitamin A ester, pterostilbene ester, resveratrol ester, aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, <com:Math><semantics>−N(RA)−CO2RC<annotation encoding="application / x-tex">-N(R^A)-CO_2R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(RA)−CO2RB<annotation encoding="application / x-tex">-N(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, and substituted heterocycle are substituted with one to five substituents independently selected from the group consisting of -(C1-C6)alkyl, -(C2-C6)alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^C)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)R3C<annotation encoding="application / x-tex">-NR^{C}_{3}(O)R^{C}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{C}_{3}(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NR3C(O)NR2C<annotation encoding="application / x-tex">-NR^{C}_{3}(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3CSO2NR2C<annotation encoding="application / x-tex">-NR^{C}_{3}SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SR3C<annotation encoding="application / x-tex">-SR^{C}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OSO2(C1−C6)<annotation encoding="application / x-tex">-OSO_{2}(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−SO2NR2C<annotation encoding="application / x-tex">-SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0043] wherein when <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is hydrogen, <com:Math><semantics>Z2<annotation encoding="application / x-tex">Z^2< / annotation>< / semantics>< / com:Math> is oxygen, and n is 0, the compound or derivative having formula (I) may optionally take the form of the carboxylate anion conjugate species of the compound or derivative having formula (I), further optionally associated with a positively charged counterion selected from the group consisting of calcium, magnesium, potassium, sodium, zinc, and ammonium cations;
[0044] R<com:Sup>A< / com:Sup> is selected from the group consisting of -H, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(CH<com:Sub>2< / com:Sub>)<com:Sub>3< / com:Sub>-NH-C(NH<com:Sub>2< / com:Sub>)(=NH), -CH<com:Sub>2< / com:Sub>C(=O)NH<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>COOH, -CH<com:Sub>2< / com:Sub>SH, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>C(=O)-NH<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>COOH, -CH<com:Sub>2< / com:Sub>-(2-imidazolyl), -CH(CH<com:Sub>3< / com:Sub>)-CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>4< / com:Sub>-NH<com:Sub>2< / com:Sub>, <com:Math><semantics>−(CH2)2−S−CH3<annotation encoding="application / x-tex">-(CH_2)_2-S-CH_3< / annotation>< / semantics>< / com:Math>, phenyl, <com:Math><semantics>−CH2−phenyl<annotation encoding="application / x-tex">-CH_2-phenyl< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2−OH<annotation encoding="application / x-tex">-CH_2-OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH(OH)−CH3<annotation encoding="application / x-tex">-CH(OH)-CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2−(3−indolyl)<annotation encoding="application / x-tex">-CH_2-(3-indolyl)< / annotation>< / semantics>< / com:Math>, -CH<com:Sub>2< / com:Sub>-(4-hydroxyphenyl), -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -NH<com:Sub>2< / com:Sub>, and -CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>;
[0045] each R<com:Sup>B< / com:Sup> is independently hydrogen or –(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl;
[0046] each R<com:Sup>C< / com:Sup> is independently selected from the group consisting of hydrogen, -(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted pyridyl, substituted or unsubstituted 1,4- dihydropyridyl, a radical of a compound or derivative having formula (I), and vitamin B7 ester (biotinyl); wherein the substituted pyridyl and substituted 1,4-dihydropyridyl are substituted with one to five substituents independently selected from the group consisting of <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RB<annotation encoding="application / x-tex">-C(O)R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORB<annotation encoding="application / x-tex">-C(O)OR^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2B<annotation encoding="application / x-tex">-C(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRB)NR2B<annotation encoding="application / x-tex">-C(=NR^{B})NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OR3B<annotation encoding="application / x-tex">-OR^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NR2B<annotation encoding="application / x-tex">-OC(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2BC(O)RB<annotation encoding="application / x-tex">-NR^{B}_{2}C(O)R^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2BC(O)C(C1−C6)<annotation encoding="application / x-tex">-NR^{B}_{2}C(O)C(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NRBC(O)NR2B<annotation encoding="application / x-tex">-NR^{B}C(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRBSO2NR2B<annotation encoding="application / x-tex">-NR^{B}SO_{2}NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRB<annotation encoding="application / x-tex">-SR^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RB<annotation encoding="application / x-tex">-S(O)R^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RB<annotation encoding="application / x-tex">-SO_{2}R^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2(C1−C6)<annotation encoding="application / x-tex">-SO_{2}(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−SO2NR2B<annotation encoding="application / x-tex">-SO_{2}NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>B< / com:Sup>;
[0047] R<com:Sup>2< / com:Sup>, R<com:Sup>3< / com:Sup>, R<com:Sup>4< / com:Sup>, and R<com:Sup>5< / com:Sup> are each independently selected from the group consisting of hydrogen, –(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, –(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, –(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, –CN, –NO<com:Sub>2< / com:Sub>, –C(O)R<com:Sup>C< / com:Sup>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NRCC(O)NR2C<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NR2C<annotation encoding="application / x-tex">-NR^{C}SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0048] R<com:Sup>6< / com:Sup> is selected from the group consisting of hydrogen, -C(O)R', -C(O)OR', -C(O)NHR', substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, and substituted or unsubstituted heterocycle, vitamin B1 ester, vitamin B2 ester, vitamin B6 ester, choline ester, biotin ester, vitamin A ester, resveratrol ester, glutathione ester, glutathione disulfide ester, aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, -N(R<com:Sup>A< / com:Sup>)-CO<com:Sub>2< / com:Sub>R<com:Sup>C< / com:Sup>, -N(R<com:Sup>A< / com:Sup>)-CO<com:Sub>2< / com:Sub>R<com:Sup>B< / com:Sup>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, and substituted heterocycle are substituted with one to five substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, -CN, -NO<com:Sub>2< / com:Sub>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)alkyl<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_1-C_6)alkyl< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCC(O)NRC2<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NRC2<annotation encoding="application / x-tex">-NR^{C}SO_2NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_2R^{C}< / annotation>< / semantics>< / com:Math>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0049] R' is selected from the group consisting of hydrogen, substituted or unsubstituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycle, vitamin B1 ester, vitamin B2 ester, vitamin B6 ester, choline ester, biotin ester, vitamin A ester, resveratrol ester, aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, –N(R<com:Sup>A< / com:Sup>)–CO<com:Sub>2< / com:Sub>R<com:Sup>C< / com:Sup>, –N(R<com:Sup>A< / com:Sup>)–CO<com:Sub>2< / com:Sub>R<com:Sup>B< / com:Sup>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, and substituted heterocycle are substituted with one to five substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, -CN, -NO<com:Sub>2< / com:Sub>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)alkyl<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_1-C_6)alkyl< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCC(O)NRC2<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NRC2<annotation encoding="application / x-tex">-NR^{C}SO_2NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_2R^{C}< / annotation>< / semantics>< / com:Math>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0050] R<com:Sup>7< / com:Sup> and R<com:Sup>8< / com:Sup> are independently selected from the group consisting of hydrogen, -C(O)R', -C(O)OR', -C(O)NHR', substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycle, substituted or unsubstituted aryl(C<com:Sub>1< / com:Sub>- C<com:Sub>4< / com:Sub>)alkyl, and substituted or unsubstituted heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, substituted heterocycle, substituted aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, and substituted heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl are substituted with one to five substituents independently selected from the group consisting of <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)alkyl<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_1-C_6)alkyl< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCC(O)NRC2<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NRC2<annotation encoding="application / x-tex">-NR^{C}SO_2NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_2R^{C}< / annotation>< / semantics>< / com:Math>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0051] provided that the absolute configuration of <com:Math><semantics>C**<annotation encoding="application / x-tex">C^{**}< / annotation>< / semantics>< / com:Math> is R or S, or a mixture of R and S.
[0052] In accordance with such an embodiment, appropriate starting materials for the methods of the present disclosure for the preparation of compounds or derivatives having formula (I), or salts, solvates, or prodrugs thereof, include compounds or derivatives having formula (1), or salts thereof: [Image disponible dans le document PDF, Image available in the PDF document] (1)
[0053] wherein <com:Math><semantics>ℤ1<annotation encoding="application / x-tex">\mathbb{Z}^1< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>ℤ2<annotation encoding="application / x-tex">\mathbb{Z}^2< / annotation>< / semantics>< / com:Math> are independently nitrogen or oxygen;
[0054] m is 1 or 2;
[0055] n is 0 or 1;
[0056] each R<com:Sup>1< / com:Sup> is independently selected from the group consisting of hydrogen, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, and substituted or unsubstituted heterocycle, vitamin B1 ester, vitamin B2 ester, vitamin B6 ester, choline ester, biotin ester, vitamin A ester, pterostilbene ester, resveratrol ester, aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, heterocycle(C<com:Sub>1< / com:Sub>- <com:Math><semantics>C4<annotation encoding="application / x-tex">C_4< / annotation>< / semantics>< / com:Math>)alkyl, <com:Math><semantics>−N(RA)−CO2RC<annotation encoding="application / x-tex">-N(R^A)-CO_2R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(RA)−CO2RB<annotation encoding="application / x-tex">-N(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, and substituted heterocycle are substituted with one to five substituents independently selected from the group consisting of -(C1-C6)alkyl, -(C2-C6)alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^C)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)R1C<annotation encoding="application / x-tex">-NR^{C}_{3}(O)R^{C}_{1}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{C}_{3}(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NR3C(O)NR2C<annotation encoding="application / x-tex">-NR^{C}_{3}(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)NR2C<annotation encoding="application / x-tex">-NR^{C}_{3}(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SR3C<annotation encoding="application / x-tex">-SR^{C}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OSO2(C1−C6)<annotation encoding="application / x-tex">-OSO_{2}(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−SO2NR2C<annotation encoding="application / x-tex">-SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0057] wherein when each <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is hydrogen, <com:Math><semantics>Z2<annotation encoding="application / x-tex">Z^2< / annotation>< / semantics>< / com:Math> is oxygen, m is 1, and n is 0, the compound or derivative having formula (1) may optionally take the form of the carboxylate anion conjugate base species of the compound or derivative having formula (1), further optionally associated with a positively charged counterion selected from the group consisting of calcium, magnesium, potassium, sodium, zinc, and ammonium cations;
[0058] R<com:Sup>A< / com:Sup> is selected from the group consisting of -H, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(CH<com:Sub>2< / com:Sub>)<com:Sub>3< / com:Sub>-NH-C(NH<com:Sub>2< / com:Sub>)(=NH), -CH<com:Sub>2< / com:Sub>C(=O)NH<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>COOH, -CH<com:Sub>2< / com:Sub>SH, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>C(=O)-NH<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>COOH, -CH<com:Sub>2< / com:Sub>-(2-imidazolyl), -CH(CH<com:Sub>3< / com:Sub>)-CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>4< / com:Sub>-NH<com:Sub>2< / com:Sub>, <com:Math><semantics>−(CH2)2−S−CH3<annotation encoding="application / x-tex">-(CH_2)_2-S-CH_3< / annotation>< / semantics>< / com:Math>, phenyl, <com:Math><semantics>−CH2−phenyl<annotation encoding="application / x-tex">-CH_2-phenyl< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2−OH<annotation encoding="application / x-tex">-CH_2-OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH(OH)−CH3<annotation encoding="application / x-tex">-CH(OH)-CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2−(3−indolyl)<annotation encoding="application / x-tex">-CH_2-(3-indolyl)< / annotation>< / semantics>< / com:Math>, -CH<com:Sub>2< / com:Sub>-(4-hydroxyphenyl), -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -NH<com:Sub>2< / com:Sub>, and -CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>;
[0059] each R<com:Sup>B< / com:Sup> is independently hydrogen or –(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl;
[0060] each R<com:Sup>C< / com:Sup> is independently selected from the group consisting of hydrogen, -(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted pyridyl, substituted or unsubstituted 1,4- dihydropyridyl, a radical of a compound or derivative having formula (I), and vitamin B7 ester (biotinyl); wherein the substituted pyridyl and substituted 1,4-dihydropyridyl are substituted with one to five substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, -CN, -NO<com:Sub>2< / com:Sub>, -C(O)R<com:Sup>B< / com:Sup>, -C(O)OR<com:Sup>B< / com:Sup>, <com:Math><semantics>−C(O)NR2B<annotation encoding="application / x-tex">-C(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRB)NR2B<annotation encoding="application / x-tex">-C(=NR^{B})NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OR3B<annotation encoding="application / x-tex">-OR^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NR2B<annotation encoding="application / x-tex">-OC(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R3B<annotation encoding="application / x-tex">R^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR4B<annotation encoding="application / x-tex">-NR^{B}_{4}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R3B<annotation encoding="application / x-tex">R^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR4B<annotation encoding="application / x-tex">-NR^{B}_{4}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R3B<annotation encoding="application / x-tex">R^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR4B<annotation encoding="application / x-tex">-NR^{B}_{4}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R3B<annotation encoding="application / x-tex">R^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR4B<annotation encoding="application / x-tex">-NR^{B}_{4}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R3B<annotation encoding="application / x-tex">R^{B}_{3}< / annotation>< / semantics>< / com:Math> -NR<com:Sup>B< / com:Sup>C(O)NR<com:Sup>B< / com:Sup><com:Sub>2< / com:Sub>, -NR<com:Sup>B< / com:Sup>SO<com:Sub>2< / com:Sub>NR<com:Sup>B< / com:Sup><com:Sub>2< / com:Sub>, -SR<com:Sup>B< / com:Sup>, -S(O)R<com:Sup>B< / com:Sup>, -SO<com:Sub>2< / com:Sub>R<com:Sup>B< / com:Sup>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>B< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>B< / com:Sup>;
[0061] R<com:Sup>2< / com:Sup>, R<com:Sup>3< / com:Sup>, R<com:Sup>4< / com:Sup>, and R<com:Sup>5< / com:Sup> are each independently selected from the group consisting of hydrogen, –(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, –(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, –(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, –CN, –NO<com:Sub>2< / com:Sub>, –C(O)R<com:Sup>C< / com:Sup>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NRCC(O)NR2C<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NR2C<annotation encoding="application / x-tex">-NR^{C}SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, –OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, –SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, –(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and –(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene–OR<com:Sup>C< / com:Sup>;
[0062] provided that the absolute configuration of <com:Math><semantics>C**<annotation encoding="application / x-tex">C^{**}< / annotation>< / semantics>< / com:Math> is R or S, or a mixture of R and S.
[0063] In accordance with such an embodiment, appropriate starting materials for the methods of the present disclosure for the preparation of compounds or derivatives having formula (I), or salts, solvates, or prodrugs thereof, include compounds or derivatives having formula (2), or salts thereof: [Image disponible dans le document PDF, Image available in the PDF document] (2)
[0064] wherein X' is selected from the group consisting of fluoro, chloro, bromo, iodo, HCO<com:Sub>2< / com:Sub>, acetoxy, propionoxy, butyroxy, glutamyloxy, aspartyloxy, ascorbyloxy, benzoxy, HOCO<com:Sub>2< / com:Sub>, citryloxy, carbamyloxy, gluconyloxy, lactyloxy, succinyloxy, sulfoxy, trifluoromethanesulfoxy, trichloromethanesulfoxy, tribromomethanesulfoxy, and trifluoroacetoxy;
[0065] R<com:Sup>6< / com:Sup> is selected from the group consisting of hydrogen, -C(O)R', -C(O)OR', -C(O)NHR', substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, and substituted or unsubstituted heterocycle, vitamin B1 ester, vitamin B2 ester, vitamin B6 ester, choline ester, biotin ester, vitamin A ester, resveratrol ester, glutathione ester, glutathione disulfide ester, aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, -N(R<com:Sup>A< / com:Sup>)-CO<com:Sub>2< / com:Sub>R<com:Sup>C< / com:Sup>, -N(R<com:Sup>A< / com:Sup>)-CO<com:Sub>2< / com:Sub>R<com:Sup>B< / com:Sup>, -C**H-(R<com:Sup>A< / com:Sup>)-NH<com:Sub>2< / com:Sub>, and -C**H-(R<com:Sup>A< / com:Sup>)-CO<com:Sub>2< / com:Sub>R<com:Sup>B< / com:Sup>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, and substituted heterocycle are substituted with one to five substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, -CN, -NO<com:Sub>2< / com:Sub>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)alkyl<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_1-C_6)alkyl< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCC(O)NRC2<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NRC2<annotation encoding="application / x-tex">-NR^{C}SO_2NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_2R^{C}< / annotation>< / semantics>< / com:Math>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0066] R' is selected from the group consisting of hydrogen, substituted or unsubstituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycle, vitamin B1 ester, vitamin B2 ester, vitamin B6 ester, choline ester, biotin ester, vitamin A ester, resveratrol ester, aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, –N(R<com:Sup>A< / com:Sup>)–CO<com:Sub>2< / com:Sub>R<com:Sup>C< / com:Sup>, –N(R<com:Sup>A< / com:Sup>)–CO<com:Sub>2< / com:Sub>R<com:Sup>B< / com:Sup>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, and substituted heterocycle are substituted with one to five substituents independently selected from the group consisting of –(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, –(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, –(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, –CN, –NO<com:Sub>2< / com:Sub>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)alkyl<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_1-C_6)alkyl< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCC(O)NRC2<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NRC2<annotation encoding="application / x-tex">-NR^{C}SO_2NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_2R^{C}< / annotation>< / semantics>< / com:Math>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0067] R<com:Sup>A< / com:Sup> is selected from the group consisting of -H, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, <com:Math><semantics>−(CH2)3−NH−C(NH2)(=NH)<annotation encoding="application / x-tex">-(CH_2)_3-NH-C(NH_2)(=NH)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(=O)NH2<annotation encoding="application / x-tex">-CH_2C(=O)NH_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2COOH<annotation encoding="application / x-tex">-CH_2COOH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2SH<annotation encoding="application / x-tex">-CH_2SH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)2C(=O)−NH2<annotation encoding="application / x-tex">-(CH_2)_2C(=O)-NH_2< / annotation>< / semantics>< / com:Math>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>COOH, -CH<com:Sub>2< / com:Sub>-(2-imidazolyl), -CH(CH<com:Sub>3< / com:Sub>)-CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>4< / com:Sub>-NH<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>-S-CH<com:Sub>3< / com:Sub>, phenyl, -CH<com:Sub>2< / com:Sub>-phenyl, -CH<com:Sub>2< / com:Sub>-OH, -CH(OH)-CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>-(3-indolyl), -CH<com:Sub>2< / com:Sub>-(4-hydroxyphenyl), -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -NH<com:Sub>2< / com:Sub>, and -CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>;
[0068] each R<com:Sup>B< / com:Sup> is independently hydrogen or –(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl;
[0069] each R<com:Sup>C< / com:Sup> is independently selected from the group consisting of hydrogen, -(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted pyridyl, substituted or unsubstituted 1,4- dihydropyridyl, a radical of a compound or derivative having formula (I), and vitamin B7 ester (biotinyl); wherein the substituted pyridyl and substituted 1,4-dihydropyridyl are substituted with one to five substituents independently selected from the group consisting of <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RB<annotation encoding="application / x-tex">-C(O)R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORB<annotation encoding="application / x-tex">-C(O)OR^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2B<annotation encoding="application / x-tex">-C(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRB)NR2B<annotation encoding="application / x-tex">-C(=NR^{B})NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OR3B<annotation encoding="application / x-tex">-OR^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NR2B<annotation encoding="application / x-tex">-OC(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRBC(O)RB<annotation encoding="application / x-tex">-NR^{B}C(O)R^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRBC(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{B}C(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NRBC(O)NR2B<annotation encoding="application / x-tex">-NR^{B}C(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRBSO2NR2B<annotation encoding="application / x-tex">-NR^{B}SO_{2}NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRB<annotation encoding="application / x-tex">-SR^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RB<annotation encoding="application / x-tex">-S(O)R^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RB<annotation encoding="application / x-tex">-SO_{2}R^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OSO2(C1−C6)<annotation encoding="application / x-tex">-OSO_{2}(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−SO2NR2B<annotation encoding="application / x-tex">-SO_{2}NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>B< / com:Sup>;
[0070] R<com:Sup>7< / com:Sup> and R<com:Sup>8< / com:Sup> are independently selected from the group consisting of hydrogen, -C(O)R', -C(O)OR', -C(O)NHR', substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycle, substituted or unsubstituted aryl(C<com:Sub>1< / com:Sub>- C<com:Sub>4< / com:Sub>)alkyl, and substituted or unsubstituted heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, substituted heterocycle, substituted aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, and substituted heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl are substituted with one to five substituents independently selected from the group consisting of -(C1-C6)alkyl, -(C2-C6)alkenyl, -(C2-C6)alkynyl, halogen, -CN, -NO2, -C(O)R<com:Sup>C< / com:Sup>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)alkyl<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_1-C_6)alkyl< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCC(O)NRC2<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NRC2<annotation encoding="application / x-tex">-NR^{C}SO_2NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_2R^{C}< / annotation>< / semantics>< / com:Math>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0071] provided that the absolute configuration of <com:Math><semantics>C**<annotation encoding="application / x-tex">C^{**}< / annotation>< / semantics>< / com:Math> is R or S, or a mixture of R and S.
[0072] In accordance with such an embodiment, appropriate starting materials for the methods of the present disclosure for the preparation of compounds or derivatives having formula (2), or salts, solvates, or prodrugs thereof, include compounds or derivatives having formula (2a), or salts thereof: [Image disponible dans le document PDF, Image available in the PDF document] (2a)
[0073] wherein R<com:Sup>6< / com:Sup> is selected from the group consisting of hydrogen, -C(O)R', -C(O)OR', -C(O)NHR', substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, and substituted or unsubstituted heterocycle, vitamin B1 ester, vitamin B2 ester, vitamin B6 ester, choline ester, biotin ester, vitamin A ester, resveratrol ester, glutathione ester, glutathione disulfide ester, aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, -N(R<com:Sup>A< / com:Sup>)-CO<com:Sub>2< / com:Sub>R<com:Sup>C< / com:Sup>, -N(R<com:Sup>A< / com:Sup>)-CO<com:Sub>2< / com:Sub>R<com:Sup>B< / com:Sup>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, and substituted heterocycle are substituted with one to five substituents independently selected from the group consisting of –(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, –(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, –(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, –CN, –NO<com:Sub>2< / com:Sub>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NR2C<annotation encoding="application / x-tex">-OC(O)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^C_2< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NRCC(O)NR2C<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NR2C<annotation encoding="application / x-tex">-NR^{C}SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0074] R' is selected from the group consisting of hydrogen, substituted or unsubstituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycle, vitamin B1 ester, vitamin B2 ester, vitamin B6 ester, choline ester, biotin ester, vitamin A ester, resveratrol ester, aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, <com:Math><semantics>−N(RA)−CO2RC<annotation encoding="application / x-tex">-N(R^{A})-CO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(RA)−CO2RB<annotation encoding="application / x-tex">-N(R^{A})-CO_{2}R^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^{A})-NH_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^{A})-CO_{2}R^{B}< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, and substituted heterocycle are substituted with one to five substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^C)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)R3C<annotation encoding="application / x-tex">-NR^{C}_{3}(O)R^{C}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{C}_{3}(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NR3C(O)NR2C<annotation encoding="application / x-tex">-NR^{C}_{3}(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3CSO2NR2C<annotation encoding="application / x-tex">-NR^{C}_{3}SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SR3C<annotation encoding="application / x-tex">-SR^{C}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OSO2(C1−C6)<annotation encoding="application / x-tex">-OSO_{2}(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−SO2NR2C<annotation encoding="application / x-tex">-SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0075] R<com:Sup>A< / com:Sup> is selected from the group consisting of -H, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(CH<com:Sub>2< / com:Sub>)<com:Sub>3< / com:Sub>-NH-C(NH<com:Sub>2< / com:Sub>)(=NH), -CH<com:Sub>2< / com:Sub>C(=O)NH<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>COOH, -CH<com:Sub>2< / com:Sub>SH, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>C(=O)-NH<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>COOH, -CH<com:Sub>2< / com:Sub>-(2-imidazolyl), -CH(CH<com:Sub>3< / com:Sub>)-CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>4< / com:Sub>-NH<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>-S-CH<com:Sub>3< / com:Sub>, phenyl, -CH<com:Sub>2< / com:Sub>-phenyl, -CH<com:Sub>2< / com:Sub>-OH, -CH(OH)-CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>-(3-indolyl), -CH<com:Sub>2< / com:Sub>-(4-hydroxyphenyl), -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -NH<com:Sub>2< / com:Sub>, and -CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>;
[0076] each R<com:Sup>B< / com:Sup> is independently hydrogen or –(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl;
[0077] each R<com:Sup>C< / com:Sup> is independently selected from the group consisting of hydrogen, -(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted pyridyl, substituted or unsubstituted 1,4- dihydropyridyl, a radical of a compound or derivative having formula (I), and vitamin B7 ester (biotinyl); wherein the substituted pyridyl and substituted 1,4-dihydropyridyl are substituted with one to five substituents independently selected from the group consisting of <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RB<annotation encoding="application / x-tex">-C(O)R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORB<annotation encoding="application / x-tex">-C(O)OR^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2B<annotation encoding="application / x-tex">-C(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRB)NR2B<annotation encoding="application / x-tex">-C(=NR^{B})NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OR3B<annotation encoding="application / x-tex">-OR^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NR2B<annotation encoding="application / x-tex">-OC(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRBC(O)RB<annotation encoding="application / x-tex">-NR^{B}C(O)R^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRBC(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{B}C(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NRBC(O)NR2B<annotation encoding="application / x-tex">-NR^{B}C(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRBSO2NR2B<annotation encoding="application / x-tex">-NR^{B}SO_{2}NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRB<annotation encoding="application / x-tex">-SR^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RB<annotation encoding="application / x-tex">-S(O)R^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RB<annotation encoding="application / x-tex">-SO_{2}R^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OSO2(C1−C6)<annotation encoding="application / x-tex">-OSO_{2}(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−SO2NR2B<annotation encoding="application / x-tex">-SO_{2}NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>B< / com:Sup>;
[0078] R<com:Sup>7< / com:Sup> and R<com:Sup>8< / com:Sup> are independently selected from the group consisting of hydrogen, -C(O)R', -C(O)OR', -C(O)NHR', substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycle, substituted or unsubstituted aryl(C<com:Sub>1< / com:Sub>- C<com:Sub>4< / com:Sub>)alkyl, substituted or unsubstituted heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl; wherein the substituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, substituted heterocycle, substituted aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, and substituted heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl are substituted with one to five substituents independently selected from the group consisting of [Image disponible dans le document PDF, Image available in the PDF document]
[0079] R<com:Sup>14< / com:Sup> is methyl or phenyl;
[0080] provided that the absolute configuration of <com:Math><semantics>C**<annotation encoding="application / x-tex">C^{**}< / annotation>< / semantics>< / com:Math> is R or S, or a mixture of R and S.
[0081] Generally, appropriate synthetic processes comprising batch processing or continuous processing of reagents by liquid-assisted mixing, milling, grinding, and / or extrusion are employed as described.
[0082] In accordance with an alternative embodiment, appropriate starting materials for the methods of the present disclosure for the preparation of compounds or derivatives having formula (I), or salts, solvates, or prodrugs thereof, include compounds or derivatives having formula (1a), or salts thereof: [Image disponible dans le document PDF, Image available in the PDF document] (1a)
[0083] wherein <com:Math><semantics>Z1<annotation encoding="application / x-tex">Z^1< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>Z2<annotation encoding="application / x-tex">Z^2< / annotation>< / semantics>< / com:Math> are independently NH or oxygen;
[0084] n is 0 or 1;
[0085] R<com:Sup>1< / com:Sup> is selected from the group consisting of hydrogen, substituted or unsubstituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, and substituted or unsubstituted heterocycle, vitamin B1 ester, vitamin B2 ester, vitamin B6 ester, choline ester, biotin ester, vitamin A ester, pterostilbene ester, resveratrol ester, aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, <com:Math><semantics>−N(RA)−CO2RC<annotation encoding="application / x-tex">-N(R^A)-CO_2R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(RA)−CO2RB<annotation encoding="application / x-tex">-N(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, and substituted heterocycle are substituted with one to five substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^C)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)R3C<annotation encoding="application / x-tex">-NR^{C}_{3}(O)R^{C}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{C}_{3}(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NR3C(O)NR2C<annotation encoding="application / x-tex">-NR^{C}_{3}(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3CSO2NR2C<annotation encoding="application / x-tex">-NR^{C}_{3}SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SR3C<annotation encoding="application / x-tex">-SR^{C}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OSO2(C1−C6)<annotation encoding="application / x-tex">-OSO_{2}(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−SO2NR2C<annotation encoding="application / x-tex">-SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0086] wherein when <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is hydrogen, <com:Math><semantics>Z2<annotation encoding="application / x-tex">Z^2< / annotation>< / semantics>< / com:Math> is oxygen, and n is 0, the compound or derivative having formula (1a) may optionally take the form of the carboxylate anion conjugate base species of the compound or derivative having formula (1a), further optionally associated with a positively charged counterion selected from the group consisting of calcium, magnesium, potassium, sodium, zinc, and ammonium cations;
[0087] R<com:Sup>A< / com:Sup> is selected from the group consisting of –H, –(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, <com:Math><semantics>−(CH2)3−NH−C(NH2)(=NH)<annotation encoding="application / x-tex">-(CH_2)_3-NH-C(NH_2)(=NH)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(=O)NH2<annotation encoding="application / x-tex">-CH_2C(=O)NH_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2COOH<annotation encoding="application / x-tex">-CH_2COOH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2SH<annotation encoding="application / x-tex">-CH_2SH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)2C(=O)−NH2<annotation encoding="application / x-tex">-(CH_2)_2C(=O)-NH_2< / annotation>< / semantics>< / com:Math>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>COOH, -CH<com:Sub>2< / com:Sub>-(2-imidazoly), -CH(CH<com:Sub>3< / com:Sub>)-CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>4< / com:Sub>-NH<com:Sub>2< / com:Sub>, <com:Math><semantics>−(CH2)2−S−CH3<annotation encoding="application / x-tex">-(CH_2)_2-S-CH_3< / annotation>< / semantics>< / com:Math>, phenyl, <com:Math><semantics>−CH2−phenyl<annotation encoding="application / x-tex">-CH_2-phenyl< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2−OH<annotation encoding="application / x-tex">-CH_2-OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH(OH)−CH3<annotation encoding="application / x-tex">-CH(OH)-CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2−(3−indolyl)<annotation encoding="application / x-tex">-CH_2-(3-indolyl)< / annotation>< / semantics>< / com:Math>, -CH<com:Sub>2< / com:Sub>-(4-hydroxyphenyl), -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -NH<com:Sub>2< / com:Sub>, and -CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>;
[0088] each R<com:Sup>B< / com:Sup> is independently hydrogen or –(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl;
[0089] each R<com:Sup>C< / com:Sup> is independently selected from the group consisting of hydrogen, -(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted pyridyl, substituted or unsubstituted 1,4- dihydropyridyl, a radical of a compound or derivative having formula (I), and vitamin B7 ester (biotinyl); wherein the substituted pyridyl and substituted 1,4-dihydropyridyl are substituted with one to five substituents independently selected from the group consisting of <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RB<annotation encoding="application / x-tex">-C(O)R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORB<annotation encoding="application / x-tex">-C(O)OR^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2B<annotation encoding="application / x-tex">-C(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRB)NR2B<annotation encoding="application / x-tex">-C(=NR^{B})NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OR3B<annotation encoding="application / x-tex">-OR^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NR2B<annotation encoding="application / x-tex">-OC(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRBC(O)RB<annotation encoding="application / x-tex">-NR^{B}C(O)R^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRBC(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{B}C(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, -NR<com:Sup>B< / com:Sup>C(O)NR<com:Sup>B< / com:Sup><com:Sub>2< / com:Sub>, -NR<com:Sup>B< / com:Sup>SO<com:Sub>2< / com:Sub>NR<com:Sup>B< / com:Sup><com:Sub>2< / com:Sub>, -SR<com:Sup>B< / com:Sup>, -S(O)R<com:Sup>B< / com:Sup>, -SO<com:Sub>2< / com:Sub>R<com:Sup>B< / com:Sup>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>B< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>B< / com:Sup>;
[0090] each of R<com:Sup>2< / com:Sup>, R<com:Sup>3< / com:Sup>, R<com:Sup>4< / com:Sup>, and R<com:Sup>5< / com:Sup> is hydrogen;
[0091] provided that the absolute configuration of <com:Math><semantics>C**<annotation encoding="application / x-tex">C^{**}< / annotation>< / semantics>< / com:Math> is R or S, or a mixture of R and S.
[0092] In accordance with yet another alternative embodiment, appropriate starting materials for the methods of the present disclosure for the preparation of compounds or derivatives having formula I, or salts, solvates, or prodrugs thereof, include compounds or derivatives having formula (1b), or salts thereof: [Image disponible dans le document PDF, Image available in the PDF document] (1b)
[0093] wherein <com:Math><semantics>Z1<annotation encoding="application / x-tex">Z^1< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>Z2<annotation encoding="application / x-tex">Z^2< / annotation>< / semantics>< / com:Math> are independently nitrogen or oxygen;
[0094] m is 1 or 2;
[0095] n is 0 or 1;
[0096] each R<com:Sup>1< / com:Sup> is independently selected from the group consisting of hydrogen, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, and substituted or unsubstituted heterocycle, vitamin B1 ester, vitamin B2 ester, vitamin B6 ester, choline ester, biotin ester, vitamin A ester, pterostilbene ester, resveratrol ester, aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, heterocycle(C<com:Sub>1< / com:Sub>- <com:Math><semantics>C4<annotation encoding="application / x-tex">C_4< / annotation>< / semantics>< / com:Math>)alkyl, <com:Math><semantics>−N(RA)−CO2RC<annotation encoding="application / x-tex">-N(R^A)-CO_2R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(RA)−CO2RB<annotation encoding="application / x-tex">-N(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, and substituted heterocycle are substituted with one to five substituents independently selected from the group consisting of -(C1-C6)alkyl, -(C2-C6)alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^C)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)R1C<annotation encoding="application / x-tex">-NR^{C}_{3}(O)R^{C}_{1}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{C}_{3}(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NR3C(O)NR2C<annotation encoding="application / x-tex">-NR^{C}_{3}(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3CSO2NR2C<annotation encoding="application / x-tex">-NR^{C}_{3}SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SR3C<annotation encoding="application / x-tex">-SR^{C}_{3}< / annotation>< / semantics>< / com:Math>, -S(O)R<com:Sup>C< / com:Sup>, -SO<com:Sub>2< / com:Sub>R<com:Sup>C< / com:Sup>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0097] wherein when each R<com:Sup>1< / com:Sup> is hydrogen, Z<com:Sup>2< / com:Sup> is oxygen, m is 1, and n is 0, the compound or derivative having formula (1b) may optionally take the form of the carboxylate anion conjugate base species of the compound or derivative having formula (1b), further optionally associated with a positively charged counterion selected from the group consisting of calcium, magnesium, potassium, sodium, zinc, and ammonium cations;
[0098] R<com:Sup>A< / com:Sup> is selected from the group consisting of -H, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, <com:Math><semantics>−(CH2)3−NH−C(NH2)(=NH)<annotation encoding="application / x-tex">-(CH_2)_3-NH-C(NH_2)(=NH)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(=O)NH2<annotation encoding="application / x-tex">-CH_2C(=O)NH_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2COOH<annotation encoding="application / x-tex">-CH_2COOH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2SH<annotation encoding="application / x-tex">-CH_2SH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)2C(=O)−NH2<annotation encoding="application / x-tex">-(CH_2)_2C(=O)-NH_2< / annotation>< / semantics>< / com:Math>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>COOH, -CH<com:Sub>2< / com:Sub>-(2-imidazolyl), -CH(CH<com:Sub>3< / com:Sub>)-CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>4< / com:Sub>-NH<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>-S-CH<com:Sub>3< / com:Sub>, phenyl, -CH<com:Sub>2< / com:Sub>-phenyl, -CH<com:Sub>2< / com:Sub>-OH, -CH(OH)-CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>-(3-indolyl), -CH<com:Sub>2< / com:Sub>-(4-hydroxyphenyl), -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -NH<com:Sub>2< / com:Sub>, and -CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>;
[0099] each R<com:Sup>B< / com:Sup> is independently hydrogen or –(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl;
[0100] each R<com:Sup>C< / com:Sup> is independently selected from the group consisting of hydrogen, -(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted pyridyl, substituted or unsubstituted 1,4- dihydropyridyl, a radical of a compound or derivative having formula (I), and vitamin B7 ester (biotinyl); wherein the substituted pyridyl and substituted 1,4-dihydropyridyl are substituted with one to five substituents independently selected from the group consisting of <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RB<annotation encoding="application / x-tex">-C(O)R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORB<annotation encoding="application / x-tex">-C(O)OR^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2B<annotation encoding="application / x-tex">-C(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRB)NR2B<annotation encoding="application / x-tex">-C(=NR^{B})NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OR3B<annotation encoding="application / x-tex">-OR^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NR2B<annotation encoding="application / x-tex">-OC(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRBC(O)RB<annotation encoding="application / x-tex">-NR^{B}C(O)R^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRBC(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{B}C(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, -NR<com:Sup>B< / com:Sup>C(O)NR<com:Sup>B< / com:Sup><com:Sub>2< / com:Sub>, -NR<com:Sup>B< / com:Sup>SO<com:Sub>2< / com:Sub>NR<com:Sup>B< / com:Sup><com:Sub>2< / com:Sub>, -SR<com:Sup>B< / com:Sup>, -S(O)R<com:Sup>B< / com:Sup>, -SO<com:Sub>2< / com:Sub>R<com:Sup>B< / com:Sup>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>B< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>B< / com:Sup>;
[0101] each of R<com:Sup>2< / com:Sup>, R<com:Sup>3< / com:Sup>, R<com:Sup>4< / com:Sup>, and R<com:Sup>5< / com:Sup> is hydrogen;
[0102] provided that the absolute configuration of <com:Math><semantics>C**<annotation encoding="application / x-tex">C^{**}< / annotation>< / semantics>< / com:Math> is R or S, or a mixture of R and S.
[0103] In an embodiment, a method of making a compound or derivative having formula (2), or a salt thereof, can include the steps of:
[0104] (a) providing a compound or derivative having formula (2a), or a salt thereof, wherein when R<com:Sup>14< / com:Sup> of the compound or derivative having formula (2a), or salt thereof, is methyl, then X' of the compound or derivative having formula (2), or salt thereof, is not acetoxy, and wherein when R<com:Sup>14< / com:Sup> of the compound or derivative having formula (2a) or salt thereof, is phenyl, then X' of the compound or derivative having formula (2), or salt thereof, is not acetoxy; (b) treating the compound or derivative having formula (2a), or salt thereof, with at least a stoichiometric amount of a Brønsted acid or a nucleophilic substitution reagent in the presence of at least a molar equivalent amount of a polar organic solvent co-reagent; (c) processing the compound or derivative having formula (2a), or salt thereof, the Brønsted acid or nucleophilic substitution reagent, and the polar organic solvent co-reagent so as to produce the compound or derivative having formula (2), or salt thereof; and (d) isolating the compound or derivative having formula (2), or salt thereof.
[0105] Processing can be carried out under batch processing conditions or by continuously processing. Continuously processing may include one or more methods of agitation selected from the group consisting of liquid-assisted mixing under sealed conditions, grinding, and extruding. The process described herein effects a preparation of a compound or derivative having formula (2), or salt thereof, under almost solventless conditions.
[0106] The polar organic solvent co-reagent and isolation solvent employed in the above method of making a compound or derivative having formula (2), or salt thereof, individually, can be a polar organic solvent from among, for example, preferably, the Class 2 Residual Solvents listed in Table 2, or optionally, for non-human use, the Class 3 Residual Solvents listed in Table 3 in The National Formulary, United States Pharmacopeia 30 <467> (U.S. PHARMACOPEIAL CONVENTION 2006) (USP 30 at <467>).
[0107] In another embodiment, the nucleophilic substitution reagent of step (b) of the above method of making a compound or derivative having formula (2), or a salt thereof, is generated in situ by reacting an acyl chloride with an alcohol in stoichiometrically equivalent amounts.
[0108] In an embodiment, a method of making a compound or derivative having formula (I), or a salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta), can include the steps of:
[0109] (a) providing a compound or derivative having formula (2), or a salt thereof; (b) treating the compound or derivative having formula (2), or salt thereof, with a molar equivalent amount of a compound or derivative having formula (1), or a salt thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a trimethylsilyl ("TMS") group; (c) processing the compound or derivative having formula (2), or salt thereof, and the compound or derivative having formula (1), or salt thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group, so as to produce the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally produced in a particular anomeric ratio (alpha / beta); (d) removing by-products resulting from the processing step under reduced pressure and temperature-controlled conditions; (e) separately isolating unreacted compound or derivative having formula (2), or salt thereof; optionally, (e1) adding acetone; optionally, (e2) separately isolating unreacted compound or derivative having formula (1), or salt thereof; and (f) isolating the compound or derivative having formula (I), or salt, solvate, or prodrug thereof.
[0110] Processing can be carried out under batch processing conditions or by continuously processing. Continuously processing may include one or more methods of agitation selected from the group consisting of liquid-assisted mixing, milling, grinding, and extruding. The process described herein effects a preparation of a compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta).
[0111] The polar organic solvent co-reagent and isolation solvent employed in the above method of making a compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta), can be a polar organic solvent from among, for example, preferably, the Class 2 Residual Solvents listed in Table 2, or optionally, for non-human use, the Class 3 Residual Solvents listed in Table 3 in THE NATIONAL FORMULARY, UNITED STATES PHARMACOPEIA 30 <467> (U.S. PHARMACOPEIAL Convention 2006) (USP 30 at <467>).
[0112] In an alternative embodiment of the above method of making a compound or derivative having formula (I), or a salt, solvate, or prodrug thereof, the compound or derivative having formula (2), or salt thereof, is further treated with a molar equivalent of a Lewis acid in step (b).
[0113] In yet another alternative embodiment of the above method of making a compound or derivative having formula (I), or salt, solvate, or prodrug thereof, the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, is produced as a mixture of alpha- and beta-anomers in an anomeric ratio by % weight of from about 1.5:1 to about 1:4 alpha- anomer to beta-anomer.
[0114] In yet another alternative embodiment of the above method of making a compound or derivative having formula (I), or salt, solvate, or prodrug thereof, the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, is produced as the beta-anomer.
[0115] In yet another alternative embodiment of the above method of making a compound or derivative having formula (I), or salt, solvate, or prodrug thereof, the alpha- and beta-anomers of the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, can be separately isolated by a method that can further include the steps of:
[0116] (c1) adding acetone to, optionally, the compound or derivative having formula (2), or salt thereof, optionally, the compound or derivative having formula (1), or salt thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group, and the compound or derivative having formula (I), or salt, solvate, or prodrug thereof so as to precipitate the beta-anomer of the compound or derivative having formula (I), or salt, solvate, or prodrug thereof; (c2) filtering, optionally, the compound or derivative having formula (2), or salt thereof, optionally, the compound or derivative having formula (1), or salt thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group, and the compound or derivative having formula (I), or salt, solvate, or prodrug thereof so as to isolate the beta-anomer of the compound or derivative having formula (I), or salt, solvate, or prodrug thereof; (c3) washing the beta-anomer of the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, with acetone; (c4) combining the acetone from the adding and washing steps; and (c5) removing the acetone under reduced pressure; wherein the stps (c1) to (c5) are performed sequentially, following step (c).
[0117] In a particular embodiment, a method of making a crystalline form of the compound or derivative having formula (I), or a salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta), can include the steps of:
[0118] (a) adding a volume of methanol and water in a 95:5 weight: weight ratio to the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta), at room temperature, so as to dissolve approximately 15% of the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta), in the volume of methanol and water; (b) stirring the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta), at 50° C until all of the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta), apparently dissolves in the volume of methanol and water; (c) cooling the solution of the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta), in the volume of methanol and water, to -10° C with stirring so as to precipitate the crystalline form of the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta); (d) isolating the crystalline form of the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta); and (e) drying the crystalline form of the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta).
[0119] In yet another alternative embodiment of the above method of making a crystalline form of the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, the crystalline form of the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen, is crystalline Form I of nicotinamide riboside chloride, having formula (XII): [Image disponible dans le document PDF, Image available in the PDF document] (XII)
[0120] In yet another alternative embodiment, a method of making a compound or derivative having formula (I), or a salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta), can include the steps of:
[0121] (a) providing a compound or derivative having formula (1), or a salt thereof; optionally, (a1) treating the compound or derivative having formula (1), or salt thereof, with excess trimethylsilylating reagent(s), and, optionally, heating the compound or derivative having formula (1), or salt thereof, and the trimethylsilylating reagent(s), to reflux for about 12 hours so as to produce a compound or derivative having formula (1), or salt thereof, wherein each R<com:Sup>1< / com:Sup> is a trimethylsilyl ("TMS") group; optionally, (a2) cooling the mixture to room temperature; optionally, (a3) isolating the compound or derivative having formula (1), or salt thereof, wherein each R<com:Sup>1< / com:Sup> is a TMS group; (b) treating the compound or derivative having formula (1), or salt thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group, with a molar equivalent amount of a compound or derivative having formula (2), or a salt thereof, in an organic solvent co-reagent; (c) processing the compound or derivative having formula (1), or salt thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group, the compound or derivative having formula (2), or salt thereof, and the organic solvent co-reagent so as to produce the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group, optionally produced in a particular anomeric ratio (alpha / beta); (d) adding water to, optionally, the compound or derivative having formula (1), or salt thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group, optionally, the compound or derivative having formula (2), or salt thereof, the organic solvent co-reagent, and the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group, optionally in a particular anomeric ratio (alpha / beta); optionally, (d1) adding saturated NaHCO<com:Sub>3< / com:Sub> solution to, optionally, the compound or derivative having formula (1), or salt thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group, optionally, the compound or derivative having formula (2), or salt thereof, the organic solvent co-reagent, the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group, optionally in a particular anomeric ratio (alpha / beta), and water; (e) adjusting the pH of the aqueous phase; (f) separating the organic phase from the aqueous phase; (g) freeze-drying the aqueous phase to provide the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta); optionally, (g1) treating the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, with a <com:Math><semantics>(3<x<100)<annotation encoding="application / x-tex">(3 < x < 100)< / annotation>< / semantics>< / com:Math> molar equivalent amount of an alcohol and a reagent selected from the group consisting of at least a sub-molar equivalent amount of a Brønsted inorganic base, a (<com:Math><semantics>x≤20<annotation encoding="application / x-tex">x \le 20< / annotation>< / semantics>< / com:Math>) molar equivalent amount of a Brønsted inorganic acid, and a <com:Math><semantics>(3≤x<20)<annotation encoding="application / x-tex">(3 \le x < 20)< / annotation>< / semantics>< / com:Math> molar equivalent amount of an acyl choride; optionally, (g2) processing the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, the alcohol, and the reagent so as to produce a compound or derivative having formula (I), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen; and, optionally, (g3) isolating the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, wherein <com:Math><semantics>ℝ6<annotation encoding="application / x-tex">\mathbb{R}^6< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>ℝ7<annotation encoding="application / x-tex">\mathbb{R}^7< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>ℝ8<annotation encoding="application / x-tex">\mathbb{R}^8< / annotation>< / semantics>< / com:Math> are each hydrogen.
[0122] Processing can be carried out under batch processing conditions or by continuously processing. Continuously processing may include one or more methods of agitation selected from the group consisting of liquid-assisted mixing, milling, grinding, and extruding. The process described herein effects a preparation of a compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta).
[0123] The organic solvent co-reagent employed in the above method of making a compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta), can be a polar organic solvent from among, for example, preferably, the Class 2 Residual Solvents listed in Table 2, or optionally, for non-human use, the Class 3 Residual Solvents listed in Table 3 in THE NATIONAL FORMULARY, UNITED STATES PHARMACOPEIA 30 <467> (U.S. PHARMACOPEIAL CONVENTION 2006) (USP 30 at <467>).
[0124] In yet another alternative embodiment of the above method of making a compound or derivative having formula (I), or a salt, solvate, or prodrug thereof, wherein the reagent of step (g1) is Brønsted inorganic base, can further include the step of:
[0125] (g2a) neutralizing the Brønsted inorganic base using a concentrated acid solution under controlled conditions; wherein the step (g2a) is performed following step (g2).
[0126] In yet another alternative embodiment of the above method of making a compound or derivative having formula (I), or a salt, solvate, or prodrug thereof, wherein the reagent of step (g1) is Brønsted inorganic acid, can further include the step of:
[0127] (g2a) neutralizing the Brønsted inorganic acid using a concentrated basic solution under controlled conditions, wherein the step (g2a) is performed following step (g2).
[0128] In an embodiment, a method of making a compound or derivative having formula (Ia), or a salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta), can include the steps of:
[0129] (a) providing a compound or derivative having formula (2), or a salt thereof; (b) treating the compound or derivative having formula (2), or salt thereof, with a molar equivalent amount of a compound or derivative having formula (1a), or a salt thereof; (c) processing the compound or derivative having formula (2), or salt thereof, and the compound or derivative having formula (1a), or salt thereof, so as to produce the compound or derivative having formula (Ia), or salt, solvate, or prodrug thereof, optionally produced in a particular anomeric ratio (alpha / beta); (d) removing by-products resulting from the processing step under reduced pressure and temperature-controlled conditions; (e) separately isolating unreacted compound or derivative having formula (2), or salt thereof; optionally, (e1) adding acetone; optionally, (e2) separately isolating unreacted compound or derivative having formula (1a), or salt thereof; and (f) isolating the compound or derivative having formula (Ia), or salt, solvate, or prodrug thereof.
[0130] Processing can be carried out under batch processing conditions or by continuously processing. Continuously processing may include one or more methods of agitation selected from the group consisting of liquid-assisted mixing, milling, grinding, and extruding. The process described herein effects a preparation of a compound or derivative having formula (Ia), or salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta).
[0131] The polar organic solvent co-reagent and isolation solvent employed in the above method of making a compound or derivative having formula (Ia), or salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta), can be a polar organic solvent from among, for example, preferably, the Class 2 Residual Sovlents listed in Table 2, or optionally, for non-human use, the Class 3 Residual Solvents listed in Table 3 in THE NATIONAL FORMULARY, UNITED STATES PHARMACOPEIA 30 <467> (U.S. PHARMACOPEIAL CONVENTION 2006) (USP 30 at <467>).
[0132] In another embodiment, a method of making a compound or derivative having formula (Ia), or a salt, solvate, or prodrug thereof, optionally in a particular anomeric ratio (alpha / beta), can include the steps of:
[0133] (a) providing a compound or derivative having formula (2), or a salt thereof; (b) treating the compound or derivative having formula (2), or salt thereof, with a molar equivalent amount of a compound or derivative having formula (1b), or a salt thereof; (c) processing the compound or derivative having formula (2), or salt thereof, and the compound or derivative having formula (1b), or salt thereof, so as to produce the compound or derivative having formula (Ia), or salt, solvate, or prodrug thereof, optionally produced in a particular anomeric ratio (alpha / beta); (d) removing by-products resulting from the processing step under reduced pressure and temperature-controlled conditions; (e) separately isolating unreacted compound or derivative having formula (2), or salt thereof; optionally, (e1) adding acetone; optionally, (e2) separately isolating unreacted compound or derivative having formula (1b), or salt thereof; and (f) isolating the compound or derivative having formula (Ia), or salt, solvate, or prodrug thereof.
[0134] In yet another alternative embodiment of the above method of making a compound or derivative having formula (I), or a salt, solvate, or prodrug thereof, can further include the steps of:
[0135] (a1) providing a compound or derivative having formula (2a), or a salt thereof, wherein when R<com:Sup>14< / com:Sup> of the compound or derivative having formula (2a), or salt thereof, is methyl, then X' of the compound or derivative having formula (2), or salt thereof, is not acetoxy, and wherein when <com:Math><semantics>R14<annotation encoding="application / x-tex">R^{14}< / annotation>< / semantics>< / com:Math> of the compound or derivative having formula (2a), or salt thereof, is phenyl, then X' of the compound or derivative having formula (2), or salt thereof, is not benzoxy; (a2) treating the compound or derivative having formula (2a), or salt thereof, with at least a stoichiometric equivalent amount of a Brønsted acid or a nucleophilic substitution reagent in the presence of at least a molar equivalent amount of a polar organic solvent co-reagent; (a3) processing the compound or derivative having formula (2a), or salt thereof, the Brønsted acid or nucleophilic substitution reagent, and the polar organic solvent co-reagent so as to produce the compound or derivative having formula (2), or salt thereof; and (a4) isolating the compound or derivative having formula (2), or salt thereof; wherein the steps (a1) to (a4) are performed sequentially, before step (a).
[0136] In yet another alternative embodiment, the nucleophilic substitution reagent of step (a2) of the above method of making a compound or derivative having formula (2), or a salt thereof, is generated in situ, by reacting an acyl chloride with an alcohol in stoichiometrically equivalent amounts.
[0137] In accordance with one embodiment, the present disclosure provides a novel method for the preparation of compounds or derivatives having formula (I-H), or salts, solvates, or prodrugs thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen. In accordance with such an embodiment, the present disclosure provides a novel method whereby mechanic forces are used to minimize solvent quantities, decrease reaction times, increase overall conversion, and facilitate product purification in a multistep synthetic sequence, whereby by-product formation is minimized, and whereby primarily by-products that can be removed readily by filtration or evaporation are generated. Prototype product analogs of nicotinoyl riboside compounds include compounds or derivatives having formula (I-H), or salts, solvates, or prodrugs thereof, wherein <com:Math><semantics>R6<annotation encoding="application / x-tex">R^6< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>R7<annotation encoding="application / x-tex">R^7< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>R8<annotation encoding="application / x-tex">R^8< / annotation>< / semantics>< / com:Math> are each hydrogen: [Image disponible dans le document PDF, Image available in the PDF document] <com:Math><semantics>(I−H)<annotation encoding="application / x-tex">(I-H)< / annotation>< / semantics>< / com:Math>
[0138] optionally wherein X as counterion is absent, or when X is present, X is selected from the group consisting of fluoride, chloride, bromide, iodide, formate, acetate, propionate, butyrate, glutamate, aspartate, ascorbate, benzoate, carbonate, citrate, carbamate, gluconate, lactate, succinate, sulfonate, trifluoromethanesulfonate, trichloromethanesulfonate, tribromomethanesulfonate, and trifluoroacetate;
[0139] optionally wherein when X is absent, optionally the counterion is an internal salt;
[0140] <com:Math><semantics>Z1<annotation encoding="application / x-tex">Z^1< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>Z2<annotation encoding="application / x-tex">Z^2< / annotation>< / semantics>< / com:Math> are independently NH or oxygen;
[0141] n is 0 or 1;
[0142] R<com:Sup>1< / com:Sup> is selected from the group consisting of hydrogen, substituted or unsubstituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, and substituted or unsubstituted heterocycle, vitamin B1 ester, vitamin B2 ester, vitamin B6 ester, choline ester, biotin ester, vitamin A ester, pterostilbene ester, resveratrol ester, aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, <com:Math><semantics>−N(RA)−CO2RC<annotation encoding="application / x-tex">-N(R^A)-CO_2R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(RA)−CO2RB<annotation encoding="application / x-tex">-N(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, and substituted heterocycle are substituted with one to five substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^C)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCC(O)RC<annotation encoding="application / x-tex">-NR^{C}_{C}(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCC(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{C}_{C}(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NRCC(O)NR2C<annotation encoding="application / x-tex">-NR^{C}_{C}(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRSCO2NR2C<annotation encoding="application / x-tex">-NR^{C}_{S}O_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRSC<annotation encoding="application / x-tex">-SR^{C}_{S}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OSO2(C1−C6)<annotation encoding="application / x-tex">-OSO_{2}(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−SO2NR2C<annotation encoding="application / x-tex">-SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0143] wherein when <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is hydrogen, <com:Math><semantics>Z2<annotation encoding="application / x-tex">Z^2< / annotation>< / semantics>< / com:Math> is oxygen, and n is 0, the compound or derivative having formula (I-H) may optionally take the form of the carboxylate anion conjugate base species of the compound or derivative having formula (I-H), further optionally associated with a positively charged counterion selected from the group consisting of calcium, magnesium, potassium, sodium, zinc, and ammonium cations;
[0144] R<com:Sup>A< / com:Sup> is selected from the group consisting of –H, –(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, <com:Math><semantics>−(CH2)3−NH−C(NH2)(=NH)<annotation encoding="application / x-tex">-(CH_2)_3-NH-C(NH_2)(=NH)< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2C(=O)NH2<annotation encoding="application / x-tex">-CH_2C(=O)NH_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2COOH<annotation encoding="application / x-tex">-CH_2COOH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2SH<annotation encoding="application / x-tex">-CH_2SH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(CH2)2C(=O)−NH2<annotation encoding="application / x-tex">-(CH_2)_2C(=O)-NH_2< / annotation>< / semantics>< / com:Math>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>COOH, -CH<com:Sub>2< / com:Sub>-(2-imidazolyl), -CH(CH<com:Sub>3< / com:Sub>)-CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>4< / com:Sub>-NH<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>-S-CH<com:Sub>3< / com:Sub>, phenyl, -CH<com:Sub>2< / com:Sub>-phenyl, -CH<com:Sub>2< / com:Sub>-OH, -CH(OH)-CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>-(3-indolyl), -CH<com:Sub>2< / com:Sub>-(4-hydroxyphenyl), -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -NH<com:Sub>2< / com:Sub>, and -CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>;
[0145] each R<com:Sup>B< / com:Sup> is independently hydrogen or –(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl;
[0146] each R<com:Sup>C< / com:Sup> is independently selected from the group consisting of hydrogen, -(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted pyridyl, substituted or unsubstituted 1,4- dihydropyridyl, a radical of a compound or derivative having formula (I), and vitamin B7 ester (biotinyl); wherein the substituted pyridyl and substituted 1,4-dihydropyridyl are substituted with one to five substituents independently selected from the group consisting of <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RB<annotation encoding="application / x-tex">-C(O)R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORB<annotation encoding="application / x-tex">-C(O)OR^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2B<annotation encoding="application / x-tex">-C(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRB)NR2B<annotation encoding="application / x-tex">-C(=NR^{B})NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OR3B<annotation encoding="application / x-tex">-OR^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NR2B<annotation encoding="application / x-tex">-OC(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R3B<annotation encoding="application / x-tex">R^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3B<annotation encoding="application / x-tex">-NR^{B}_{3}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R1C<annotation encoding="application / x-tex">R^{C}_{1}< / annotation>< / semantics>< / com:Math>-<com:Math><semantics>R2C<annotation encoding="application / x-tex">R^{C}_{2}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R1C<annotation encoding="application / x-tex">R^{C}_{1}< / annotation>< / semantics>< / com:Math>-<com:Math><semantics>R3C<annotation encoding="application / x-tex">R^{C}_{3}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R1C<annotation encoding="application / x-tex">R^{C}_{1}< / annotation>< / semantics>< / com:Math>-<com:Math><semantics>R3C<annotation encoding="application / x-tex">R^{C}_{3}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R1C<annotation encoding="application / x-tex">R^{C}_{1}< / annotation>< / semantics>< / com:Math>-<Formule mathématique disponible dans le document PDF, Math available in the PDF document>$R^{C}_$ -NR<com:Sup>B< / com:Sup>C(O)NR<com:Sup>B< / com:Sup><com:Sub>2< / com:Sub>, -NR<com:Sup>B< / com:Sup>SO<com:Sub>2< / com:Sub>NR<com:Sup>B< / com:Sup><com:Sub>2< / com:Sub>, -SR<com:Sup>B< / com:Sup>, -S(O)R<com:Sup>B< / com:Sup>, -SO<com:Sub>2< / com:Sub>R<com:Sup>B< / com:Sup>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>B< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>B< / com:Sup>;
[0147] R<com:Sup>2< / com:Sup>, R<com:Sup>3< / com:Sup>, R<com:Sup>4< / com:Sup>, and R<com:Sup>5< / com:Sup> are each independently selected from the group consisting of hydrogen, –(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, –(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, –(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, –CN, –NO<com:Sub>2< / com:Sub>, –C(O)R<com:Sup>C< / com:Sup>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)alkyl<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_1-C_6)alkyl< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCC(O)NRC2<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NRC2<annotation encoding="application / x-tex">-NR^{C}SO_2NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_2R^{C}< / annotation>< / semantics>< / com:Math>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0148] provided that the absolute configuration of <com:Math><semantics>C**<annotation encoding="application / x-tex">C^{**}< / annotation>< / semantics>< / com:Math> is R or S, or a mixture of R and S.
[0149] In an embodiment, a method of making a compound or derivative having formula (I- H), or a salt, solvate, or prodrug thereof, wherein <com:Math><semantics>ℝ6<annotation encoding="application / x-tex">\mathbb{R}^6< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>ℝ7<annotation encoding="application / x-tex">\mathbb{R}^7< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>ℝ8<annotation encoding="application / x-tex">\mathbb{R}^8< / annotation>< / semantics>< / com:Math> are each hydrogen:
[0150] (a) providing a compound or derivative having formula (I), or a salt, solvate, or prodrug thereof, wherein <com:Math><semantics>R6<annotation encoding="application / x-tex">R^6< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>R7<annotation encoding="application / x-tex">R^7< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>R8<annotation encoding="application / x-tex">R^8< / annotation>< / semantics>< / com:Math> are each <com:Math><semantics>−C(O)R2<annotation encoding="application / x-tex">-C(O)R^2< / annotation>< / semantics>< / com:Math>, and wherein <com:Math><semantics>R2<annotation encoding="application / x-tex">R^2< / annotation>< / semantics>< / com:Math> is methyl or -C<com:Sub>1< / com:Sub>alkyl; (b) treating the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, wherein <com:Math><semantics>R6<annotation encoding="application / x-tex">R^6< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>R7<annotation encoding="application / x-tex">R^7< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>R8<annotation encoding="application / x-tex">R^8< / annotation>< / semantics>< / com:Math> are each <com:Math><semantics>−C(O)R2<annotation encoding="application / x-tex">-C(O)R^2< / annotation>< / semantics>< / com:Math>, and wherein <com:Math><semantics>R2<annotation encoding="application / x-tex">R^2< / annotation>< / semantics>< / com:Math> is methyl or -C<com:Sub>1< / com:Sub>alkyl, with a <com:Math><semantics>(3<x<20)<annotation encoding="application / x-tex">(3 < x < 20)< / annotation>< / semantics>< / com:Math> molar equivalent amount of an alcohol (e.g., methanol, or ethanol) and a reagent selected from the group consisting of at least a sub-molar equivalent amount of a Brønsted inorganic base, a (<com:Math><semantics>x≤20<annotation encoding="application / x-tex">x \le 20< / annotation>< / semantics>< / com:Math>) molar equivalent amount of a Brønsted inorganic acid, and a <com:Math><semantics>(3≤x≤20)<annotation encoding="application / x-tex">(3 \le x \le 20)< / annotation>< / semantics>< / com:Math> molar equivalent amount of an acyl chloride;; (c) processing the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each –C(O)R', and wherein R' is methyl or –C<com:Sub>1< / com:Sub>alkyl, the alcohol, and the reagent so as to produce the compound or derivative having formula (I-H), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen; and (d) isolating the compound or derivative having formula (I-H), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen.
[0151] Processing can be carried out under batch processing conditions or by continuously processing. Continuously processing may include one or more methods of agitation selected from the group consisting of liquid-assisted mixing, milling, grinding, and extruding. The process described herein effects a preparation of a compound or derivative having formula (I- H), or salt, solvate, or prodrug thereof, wherein <com:Math><semantics>R6<annotation encoding="application / x-tex">R^6< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>R7<annotation encoding="application / x-tex">R^7< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>R8<annotation encoding="application / x-tex">R^8< / annotation>< / semantics>< / com:Math> are each hydrogen.
[0152] The polar organic solvent co-reagent and isolation solvent employed in the above method of making a compound or derivative having formula (I-H), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen, can be a polar organic solvent from among, for example, preferably, the Class 2 Residual Solvents listed in Table 2, or optionally, for non-human use, the Class 3 Residual Solvents listed in Table 3 in The NATIONAL FORMULARY, UNITED STATES PHARMACOPEIA 30 <467> (U.S. PHARMACOPEIAL CONVENTION 2006) (USP 30 at <467>).
[0153] In an alternative embodiment of the above method of making a compound or derivative having formula (I-H), or a salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen, when the reagent of step (b) is Brønsted inorganic base, the method can further include the step of:
[0154] (c1) neutralizing the Brønsted inorganic base using a concentrated acid solution under controlled conditions; wherein the step (c1) is performed following step (c).
[0155] In another alternative embodiment of the above method of making a compound or derivative having formula (I-H), or a salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen, when the reagent of step (b) is Brønsted inorganic acid, the method can further include the step of:
[0156] (c1) neutralizing the Brønsted inorganic acid using a concentrated basic solution under controlled conditions; wherein the step (c1) is performed following step (c).
[0157] In yet another alternative embodiment of the above method of making a compound or derivative having formula (I-H), or a salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen, the method can further include the steps of:
[0158] (a1) providing a compound or derivative having formula (1), or a salt thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group; (a2) treating the compound or derivative having formula (1), or salt thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group, with a molar equivalent amount of a compound or derivative having formula (2), or a salt thereof, wherein <com:Math><semantics>R6<annotation encoding="application / x-tex">R^6< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>R7<annotation encoding="application / x-tex">R^7< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>R8<annotation encoding="application / x-tex">R^8< / annotation>< / semantics>< / com:Math> are each <com:Math><semantics>−C(O)R2<annotation encoding="application / x-tex">-C(O)R^2< / annotation>< / semantics>< / com:Math>, and wherein R' is methyl or <com:Math><semantics>−C1<annotation encoding="application / x-tex">-C_1< / annotation>< / semantics>< / com:Math> alkyl, in an organic solvent co-reagent; (a3) processing the compound or derivative having formula (1), or salt thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group, the compound or derivative having formula (2), or salt thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each -C(O)R', and wherein R' is methyl or -C<com:Sub>1< / com:Sub>alkyl, and the organic solvent co-reagent so as to produce a compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group; (a4) adding water to, optionally, the compound or derivative having formula (1), or salt thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group, optionally, the compound or derivative having formula (2), or salt thereof, wherein <com:Math><semantics>R6<annotation encoding="application / x-tex">R^6< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>R7<annotation encoding="application / x-tex">R^7< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>R8<annotation encoding="application / x-tex">R^8< / annotation>< / semantics>< / com:Math> are each <com:Math><semantics>−C(O)R3<annotation encoding="application / x-tex">-C(O)R^3< / annotation>< / semantics>< / com:Math>, and wherein R' is methyl or -C1alkyl, the organic solvent co-reagent, and the compound or derivative having formula (I), or salt, solvate, or prodrug thereof; and (a5) isolating the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group; wherein the steps (a1) to (a5) are performed sequentially, before step (a).
[0159] In yet another alternative embodiment of the above method of making a compound or derivative having formula (I-H), or salt, solvate, or prodrug thereof, the compound or derivative having formula (I), the compound or derivative having formula (1), or salt thereof, optionally wherein each R<com:Sup>1< / com:Sup> is a TMS group, is further treated with a molar equivalent of a Lewis acid in step (a2).
[0160] In a particular embodiment, a method of making a crystalline form of the compound or derivative having formula (I-H), or a salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen, can include the steps of:
[0161] (a) adding a volume of methanol and water in a 95:5 weight: weight ratio to the compound or derivative having formula (I-H), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen, at room temperature, so as to dissolve approximately 15% of the compound or derivative having formula (I-H), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen, in the volume of methanol and water; (b) stirring the compound or derivative having formula (I-H), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen, at 50° C until all of the compound or derivative having formula (I-H), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen, apparently dissolves in the volume of methanol and water; (c) cooling the solution of the compound or derivative having formula (I-H), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen, in the volume of methanol and water, to -10° C with stirring so as to precipitate the crystalline form of the compound or derivative having formula (I-H), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen; (d) isolating the crystalline form of the compound or derivative having formula (I-H), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup>, R<com:Sup>7< / com:Sup>, and R<com:Sup>8< / com:Sup> are each hydrogen; and (e) drying the crystalline form of the compound or derivative having formula (I-H), or salt, solvate, or prodrug thereof, wherein <com:Math><semantics>R6<annotation encoding="application / x-tex">R^6< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>R7<annotation encoding="application / x-tex">R^7< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>R8<annotation encoding="application / x-tex">R^8< / annotation>< / semantics>< / com:Math> are each hydrogen.
[0162] In accordance with one embodiment, the present disclosure provides a novel method for the preparation of compounds or derivatives having formula (II), or salts, solvates, or prodrugs thereof, such as phosphorylated analogs of nicotinoyl ribosides, in commercial quantities. In accordance with such an embodiment, the present disclosure provides a novel method whereby mechanic forces are used to minimize solvent quantities, decrease reaction times, increase overall conversion, and facilitate product purification in a multistep synthetic sequence, whereby by-product formation is minimized, and whereby primarily by-products that can be removed readily by filtration or evaporation are generated. Prototype product phosphorylated analogs of nicotinoyl riboside compounds include compounds or derivatives having formula (II), or salts, solvates, or prodrugs thereof: [Image disponible dans le document PDF, Image available in the PDF document] (II)
[0163] optionally wherein X<com:Sup>-< / com:Sup> as counterion is absent, or when X<com:Sup>-< / com:Sup> is present, X<com:Sup>-< / com:Sup> is selected from the group consisting of fluoride, chloride, bromide, iodide, formate, acetate, propionate, butyrate, glutamate, aspartate, ascorbate, benzoate, carbonate, citrate, carbamate, gluconate, lactate, methyl bromide, methyl sulfate, nitrate, phosphate, diphosphate, succinate, sulfonate, trifluoromethanesulfonate, trichloromethanesulfonate, tribromomethanesulfonate, and trifluoroacetate;
[0164] optionally wherein when X is absent, optionally the counterion is an internal salt;
[0165] each Y<com:Sup>1< / com:Sup> and Y<com:Sup>2< / com:Sup> is independently selected from the group consisting of hydrogen, sodium, potassium, lithium, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycle, substituted or unsubstituted amino, thiamine (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), pyridoxine (vitamin B6), <com:Math><semantics>−N(RA)−CO2RC<annotation encoding="application / x-tex">-N(R^A)-CO_2R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(RA)−CO2RB<annotation encoding="application / x-tex">-N(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, substituted heterocycle, and substituted amino are substituted with one to five substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, -CN, -NO<com:Sub>2< / com:Sub>, -C(O)R<com:Sup>C< / com:Sup>, -C(O)OR<com:Sup>C< / com:Sup>, -C(O)NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^C)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_1-C_6)< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>−OC(O)NR2C<annotation encoding="application / x-tex">-OC(O)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C<annotation encoding="application / x-tex">-NR^C_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR4C<annotation encoding="application / x-tex">-NR^C_4< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R3C<annotation encoding="application / x-tex">R^C_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR4C<annotation encoding="application / x-tex">-NR^C_4< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R4C<annotation encoding="application / x-tex">R^C_4< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR5C<annotation encoding="application / x-tex">-NR^C_5< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R5C<annotation encoding="application / x-tex">R^C_5< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR5C<annotation encoding="application / x-tex">-NR^C_5< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R5C<annotation encoding="application / x-tex">R^C_5< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR5C<annotation encoding="application / x-tex">-NR^C_5< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R5C<annotation encoding="application / x-tex">R^C_5< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR5C<annotation encoding="application / x-tex">-NR^C_5< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R5C<annotation encoding="application / x-tex">R^C_5< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR5C<annotation encoding="application / x-tex">-NR^C_5< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R5C<annotation encoding="application / x-tex">R^C_5< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCSO2NR2C<annotation encoding="application / x-tex">-NR^{C}SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OSO2(C1−C6)<annotation encoding="application / x-tex">-OSO_{2}(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−SO2NR2C<annotation encoding="application / x-tex">-SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0166] or, alternatively, <com:Math><semantics>Y1<annotation encoding="application / x-tex">Y^1< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>Y2<annotation encoding="application / x-tex">Y^2< / annotation>< / semantics>< / com:Math> taken together are selected from the group consisting of sodium, potassium, lithium, magnesium, calcium, strontium, barium, and substituted or unsubstituted 2-(methylenyl)phenyl; wherein the substituted 2-(methylenyl)phenyl is substituted with one to four substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, -CN, -NO<com:Sub>2< / com:Sub>, -C(O)R<com:Sup>C< / com:Sup>, -C(O)OR<com:Sup>C< / com:Sup>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OR3C<annotation encoding="application / x-tex">-OR^{C}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>RC3<annotation encoding="application / x-tex">R^{C_3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC3<annotation encoding="application / x-tex">-NR^{C_3}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>RC3<annotation encoding="application / x-tex">R^{C_3}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>RC3<annotation encoding="application / x-tex">R^{C_3}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>RC4<annotation encoding="application / x-tex">R^{C_4}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>RC5<annotation encoding="application / x-tex">R^{C_5}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>RC5<annotation encoding="application / x-tex">R^{C_5}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>RC5<annotation encoding="application / x-tex">R^{C_5}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>RC5<annotation encoding="application / x-tex">R^{C_5}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>RC5<annotation encoding="application / x-tex">R^{C_5}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>RC5<annotation encoding="application / x-tex">R^{C_5}< / annotation>< / semantics>< / com:Math>C(O <com:Math><semantics>−NRCC(O)NR2C<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NR2C<annotation encoding="application / x-tex">-NR^{C}SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OSO2(C1−C6)<annotation encoding="application / x-tex">-OSO_{2}(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−SO2NR2C<annotation encoding="application / x-tex">-SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0167] optionally wherein Y<com:Sup>3< / com:Sup> is oxygen, sulfur, or absent;
[0168] each of <com:Math><semantics>Z1<annotation encoding="application / x-tex">Z^1< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>Z2<annotation encoding="application / x-tex">Z^2< / annotation>< / semantics>< / com:Math> is independently NH or oxygen;
[0169] each of <com:Math><semantics>Z3<annotation encoding="application / x-tex">Z^3< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>Z4<annotation encoding="application / x-tex">Z^4< / annotation>< / semantics>< / com:Math> is independently nitrogen or oxygen;
[0170] m is 1 or 2;
[0171] n is 0 or 1;
[0172] q is 1 or 2;
[0173] R<com:Sup>1< / com:Sup> is selected from the group consisting of hydrogen, substituted or unsubstituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, and substituted or unsubstituted heterocycle, vitamin B1 ester, vitamin B2 ester, vitamin B6 ester, choline ester, biotin ester, vitamin A ester, pterosilbene ester, resveratrol ester, <com:Math><semantics>aryl(C1−C4)alkyl<annotation encoding="application / x-tex">aryl(C_1-C_4)alkyl< / annotation>< / semantics>< / com:Math>, heterocycle(<com:Math><semantics>C1−C4<annotation encoding="application / x-tex">C_1-C_4< / annotation>< / semantics>< / com:Math>)alkyl, <com:Math><semantics>−N(RA)−CO2RC<annotation encoding="application / x-tex">-N(R^A)-CO_2R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(RA)−CO2RB<annotation encoding="application / x-tex">-N(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, and substituted heterocycle are substituted with one to five substituents independently selected from the group consisting of –(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, –(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^C)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)RC<annotation encoding="application / x-tex">-NR^{C}_{3}(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{C}_{3}(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NR3C(O)NR2C<annotation encoding="application / x-tex">-NR^{C}_{3}(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3CSO2NR2C<annotation encoding="application / x-tex">-NR^{C}_{3}SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SR3C<annotation encoding="application / x-tex">-SR^{C}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OSO2(C1−C6)<annotation encoding="application / x-tex">-OSO_{2}(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−SO2NR2C<annotation encoding="application / x-tex">-SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0174] wherein when <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is hydrogen, <com:Math><semantics>Z2<annotation encoding="application / x-tex">Z^2< / annotation>< / semantics>< / com:Math> is oxygen, and n is 0, the compound or derivative having formula (II) may optionally take the form of the carboxylate anion conjugate base species of the compound or derivative having formula (II), further optionally associated with a positively charged counterion selected from the group consisting of calcium, magnesium, potassium, sodium, zinc, and ammonium cations;
[0175] R<com:Sup>A< / com:Sup> is selected from the group consisting of -H, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(CH<com:Sub>2< / com:Sub>)<com:Sub>3< / com:Sub>-NH-C(NH<com:Sub>2< / com:Sub>)(=NH), -CH<com:Sub>2< / com:Sub>C(=O)NH<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>COOH, -CH<com:Sub>2< / com:Sub>SH, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>C(=O)-NH<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>COOH, -CH<com:Sub>2< / com:Sub>-(2-imidazolyl), -CH(CH<com:Sub>3< / com:Sub>)-CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>4< / com:Sub>-NH<com:Sub>2< / com:Sub>, <com:Math><semantics>−(CH2)2−S−CH3<annotation encoding="application / x-tex">-(CH_2)_2-S-CH_3< / annotation>< / semantics>< / com:Math>, phenyl, <com:Math><semantics>−CH2<annotation encoding="application / x-tex">-CH_2< / annotation>< / semantics>< / com:Math>-phenyl, <com:Math><semantics>−CH2−OH<annotation encoding="application / x-tex">-CH_2-OH< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH(OH)−CH3<annotation encoding="application / x-tex">-CH(OH)-CH_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−CH2<annotation encoding="application / x-tex">-CH_2< / annotation>< / semantics>< / com:Math>-(3-indolyl), -CH<com:Sub>2< / com:Sub>-(4-hydroxyphenyl), -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -NH<com:Sub>2< / com:Sub>, and -CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>;
[0176] each R<com:Sup>B< / com:Sup> is independently hydrogen or –(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl;
[0177] each R<com:Sup>C< / com:Sup> is independently selected from the group consisting of hydrogen, -(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted pyridyl, substituted or unsubstituted 1,4- dihydropyridyl, a radical of a compound or derivative having formula (I), and vitamin B7 ester (biotinyl); wherein the substituted pyridyl and substituted 1,4-dihydropyridyl are substituted with one to five substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, -CN, -NO<com:Sub>2< / com:Sub>, -C(O)R<com:Sup>B< / com:Sup>, -C(O)OR<com:Sup>B< / com:Sup>, <com:Math><semantics>−C(O)NR2B<annotation encoding="application / x-tex">-C(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRB)NR2B<annotation encoding="application / x-tex">-C(=NR^{B})NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OR3B<annotation encoding="application / x-tex">-OR^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NR2B<annotation encoding="application / x-tex">-OC(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2BC(O)RB<annotation encoding="application / x-tex">-NR^{B}_{2}C(O)R^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2BC(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{B}_{2}C(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NRBC(O)NR2B<annotation encoding="application / x-tex">-NR^{B}C(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRBSO2NR2B<annotation encoding="application / x-tex">-NR^{B}SO_{2}NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRB<annotation encoding="application / x-tex">-SR^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RB<annotation encoding="application / x-tex">-S(O)R^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RB<annotation encoding="application / x-tex">-SO_{2}R^{B}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OSO2(C1−C6)<annotation encoding="application / x-tex">-OSO_{2}(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−SO2NR2B<annotation encoding="application / x-tex">-SO_{2}NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>B< / com:Sup>;
[0178] R<com:Sup>2< / com:Sup>, R<com:Sup>3< / com:Sup>, R<com:Sup>4< / com:Sup>, and R<com:Sup>5< / com:Sup> are each independently selected from the group consisting of hydrogen, –(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, –(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, –(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, –CN, –NO<com:Sub>2< / com:Sub>, –C(O)R<com:Sup>C< / com:Sup>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)alkyl<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_1-C_6)alkyl< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCC(O)NRC2<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NRC2<annotation encoding="application / x-tex">-NR^{C}SO_2NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_2R^{C}< / annotation>< / semantics>< / com:Math>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0179] R<com:Sup>7< / com:Sup> and R<com:Sup>8< / com:Sup> are independently selected from the group consisting of hydrogen, -C(O)R', -C(O)OR', -C(O)NHR', substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycle, substituted or unsubstituted aryl(C<com:Sub>1< / com:Sub>- C<com:Sub>4< / com:Sub>)alkyl, and substituted or unsubstituted heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, substituted heterocycle, substituted aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, and substituted heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl are substituted with one to five substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, -CN, -NO<com:Sub>2< / com:Sub>, -C(O)R<com:Sup>C< / com:Sup>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NRCC(O)NR2C<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NR2C<annotation encoding="application / x-tex">-NR^{C}SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, –OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, –SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, –(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and –(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene–OR<com:Sup>C< / com:Sup>;
[0180] R' is selected from the group consisting of hydrogen, substituted or unsubstituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycle, vitamin B1 ester, vitamin B2 ester, vitamin B6 ester, choline ester, biotin ester, vitamin A ester, resveratrol ester, aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, –N(R<com:Sup>A< / com:Sup>)–CO<com:Sub>2< / com:Sub>R<com:Sup>C< / com:Sup>, –N(R<com:Sup>A< / com:Sup>)–CO<com:Sub>2< / com:Sub>R<com:Sup>B< / com:Sup>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, and substituted heterocycle are substituted with one to five substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, -CN, -NO<com:Sub>2< / com:Sub>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)alkyl<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_1-C_6)alkyl< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCC(O)NRC2<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NRC2<annotation encoding="application / x-tex">-NR^{C}SO_2NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_2R^{C}< / annotation>< / semantics>< / com:Math>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0181] provided that the absolute configuration of <com:Math><semantics>C**<annotation encoding="application / x-tex">C^{**}< / annotation>< / semantics>< / com:Math> is R or S, or a mixture of R and S.
[0182] In an embodiment, a method of making a compound or derivative having formula (II), or a salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, can include the steps of:
[0183] (a) providing a compound or derivative having formula (I), or a salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup> is hydrogen; (b) treating the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup> is hydrogen, with, optionally, a <com:Math><semantics>(0≤x≤20)<annotation encoding="application / x-tex">(0 \le x \le 20)< / annotation>< / semantics>< / com:Math> molar equivalent amount of a Brømsted base, and a reagent selected from the group consisting of a phosphorylating reagent, a phosphorylating reagent, and a thiophosphorylating reagent; (c) processing the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup> is hydrogen, the reagent, and, optionally, the Brønsted base, so as to produce the compound or derivative having formula (II), or salt, solvate, or prodrug thereof; (d) adding, optionally, the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup> is hydrogen, optionally, the reagent, optionally, the Brønsted base, and the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, to iced water; and (e) isolating the compound or derivative having formula (II), or salt, solvate, or prodrug thereof.
[0184] In an alternative embodiment of the above method of making a compound or derivative having formula (II), or salt, solvate, or prodrug thereof, the method can further include the step of:
[0185] (e1) treating the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, with deprotection reagent(s) in a polar organic solvent co-reagent so as to remove any protecting groups of R<com:Sup>7< / com:Sup>, R<com:Sup>8< / com:Sup>, Y<com:Sup>1< / com:Sup>, and / or Y<com:Sup>2< / com:Sup>; wherein the step (e1) is performed following step (e).
[0186] In yet another alternative embodiment of the above method of making a compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein the reagent of step (b) is a phosphitylating reagent, the method can further include the steps of:
[0187] (c1) adding an oxidizing agent to, optionally, the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup> is hydrogen, optionaly, the phosphitylating reagent, optionally, the Brønsted base, and the compound or derivative having formula (II), or salt, solvate, or prodrug thereof; (c2) processing, optionally, the compound or derivative having formula (I), or salt, solvate, or prodrug thereof, wherein R<com:Sup>6< / com:Sup> is hydrogen, optionally, the phosphitylating reagent, optionally, the Brønsted base, and the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, so as to produce a compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is sulfur or oxygen; wherein the steps (c1) and (c2) are performed sequentially, following step (c).
[0188] Processing can be carried out under batch processing conditions or by continuously processing. Continuously processing may include one or more methods of agitation selected from the group consisting of liquid-assisted grinding and extruding. The process described herein effects a preparation of a compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, under almost solventless conditions.
[0189] The polar organic solvent co-reagent and isolation solvent employed in the above method of making a compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, can be a polar organic solvent from among, for example, preferably, the Class 2 Residual Solvents listed in Table 2, or optionally, for non-human use, the Class 3 Residual Solvents listed in Table 3 in THE NATIONAL FORMULARY, UNITED STATES PHARMACOPEIA 30 <467> (U.S. PHARMACOPEIAL CONVENTION 2006) (USP 30 at <467>).
[0190] In a particular embodiment, a method of making a crystalline form of the compound or derivative having formula (II), or a salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, can include the steps of:
[0191] (a) adding the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, to a volume of methanol and water in a 3:2 volume:volume ratio at room temperature; (b) stirring the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, and the volume of methanol and water so as to dissolve the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, in the volume of methanol and water; (c) filtering the solution of the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, in the volume of methanol and water, so as to remove any undissolved solids; (d) adding a volume of acetone to the solution of the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, in the volume of methanol and water, wherein the volume of acetone is about 2 to about 5 times the combined volume of methanol and water; (e) cooling the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, the volume of acetone, and the volume of methanol and water at -20° C so as to precipitate the crystalline form of the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen; (f) isolating the crystalline form of the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen; and (g) drying the crystalline form of the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein <com:Math><semantics>Y3<annotation encoding="application / x-tex">Y^3< / annotation>< / semantics>< / com:Math> is oxygen, at room temperature.
[0192] In a particular embodiment, an alternative method of making a crystalline form of the compound or derivative having formula (II), or a salt, solvate, or prodrug thereof, wherein <com:Math><semantics>Y3<annotation encoding="application / x-tex">Y^3< / annotation>< / semantics>< / com:Math> is oxygen, can include the steps of:
[0193] (a) adding the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, to a volume of methanol and water in a 3:2 volume:volume ratio at room temperature; (b) stirring the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, and the volume of methanol and water so as to dissolve the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, in the volume of methanol and water; (c) filtering the solution of the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, in the volume of methanol and water, so as to remove any undissolved solids; (d) cooling the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, and the volume of methanol and water at -20° C so as to produce an oily layer at the bottom of the volume of methanol and water; (e) decanting the volume of methanol and water from the oily layer at the bottom of the volume of methanol and water; and (f) drying the oily layer at room temperature so as to crystallize the crystalline form of the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein <com:Math><semantics>Y3<annotation encoding="application / x-tex">Y^3< / annotation>< / semantics>< / com:Math> is oxygen.
[0194] In a particular embodiment, another alternative method of making a crystalline form of the compound or derivative having formula (II), or a salt, solvate, or prodrug thereof, wherein <com:Math><semantics>Y3<annotation encoding="application / x-tex">Y^3< / annotation>< / semantics>< / com:Math> is oxygen, can include the steps of:
[0195] (a) adding the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, to a volume of ethanol and water in a 3:2 volume:volume ratio at room temperature, wherein the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, is added in an amount of about 200 milligrams per milliliter of the volume of ethanol and water; (b) stirring the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, and the volume of ethanol and water so as to dissolve the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, in the volume of ethanol and water; (c) filtering the solution of the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, in the volume of ethanol and water, so as to remove any undissolved solids; (d) cooling the compound or derivative havin formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, in the volume of ethanol and water, to -10° C for about 48 hours so as to produce the crystalline form of the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen; (e) decanting the volume of ethanol and water from the crystalline form of the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, so as to isolate the crystalline form of the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen; and (f) drying the crystalline form of the compound or derivative having formula (II), or salt, solvate, or prodrug thereof, wherein Y<com:Sup>3< / com:Sup> is oxygen, at room temperature.
[0196] In accordance with one embodiment, the present disclosure provides a novel method for the preparation of compounds or derivatives having formula (III), or salts, solvates, or prodrugs thereof, such as adenylyl dinucleotide conjugates of nicotinoyl ribosides, in commercial quantities. In accordance with such an embodiment, the present disclosure provides a novel method whereby mechanic forces are used to minimize solvent quantities, decrease reaction times, increase overall conversion, and facilitate product purification, whereby by-product formation is minimized. Prototype product nicotinoyl riboside compounds include compounds or derivatives having formula (III), or salts, solvates, or prodrugs thereof: [Image disponible dans le document PDF, Image available in the PDF document]
[0197] optionally wherein X as counterion is absent, or when X is present, X is selected from the group consisting of fluoride, chloride, bromide, iodide, formate, acetate, propionate, butyrate, glutamate, aspartate, ascorbate, benzoate, carbonate, citrate, carbamate, gluconate, lactate, methyl bromide, methyl sulfate, nitrate, phosphate, diphosphate, succinate, sulfonate, trifluoromethanesulfonate, trichloromethanesulfonate, tribromomethanesulfonate, and trifluoroacetate;
[0198] optionally wherein when X is absent, optionally the counterion is an internal salt;
[0199] each Y<com:Sup>1< / com:Sup> is independently selected from the group consisting of hydrogen, sodium, potassium, lithium, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycle, substituted or unsubstituted amino, thiamine (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), pyridoxine (vitamin B6), <com:Math><semantics>−N(RA)−CO2RC<annotation encoding="application / x-tex">-N(R^A)-CO_2R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(RA)−CO2RB<annotation encoding="application / x-tex">-N(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, substituted heterocycle, and substituted amino are substituted with one to five substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, -CN, -NO<com:Sub>2< / com:Sub>, -C(O)R<com:Sup>C< / com:Sup>, -C(O)OR<com:Sup>C< / com:Sup>, -C(O)NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^C)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_1-C_6)< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>−OC(O)NR2C<annotation encoding="application / x-tex">-OC(O)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^C_2< / annotation>< / semantics>< / com:Math>(O)<com:Math><semantics>RC<annotation encoding="application / x-tex">R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C<annotation encoding="application / x-tex">-NR^C_3< / annotation>< / semantics>< / com:Math>(O)<com:Math><semantics>R4C<annotation encoding="application / x-tex">R^C_4< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR4C<annotation encoding="application / x-tex">-NR^C_4< / annotation>< / semantics>< / com:Math>(O)<com:Math><semantics>R4C<annotation encoding="application / x-tex">R^C_4< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR5C<annotation encoding="application / x-tex">-NR^C_5< / annotation>< / semantics>< / com:Math>(O)<com:Math><semantics>R4C<annotation encoding="application / x-tex">R^C_4< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR5C<annotation encoding="application / x-tex">-NR^C_5< / annotation>< / semantics>< / com:Math>(O)<com:Math><semantics>R5C<annotation encoding="application / x-tex">R^C_5< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCSO2NR2C<annotation encoding="application / x-tex">-NR^{C}SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OSO2(C1−C6)<annotation encoding="application / x-tex">-OSO_{2}(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−SO2NR2C<annotation encoding="application / x-tex">-SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0200] each W<com:Sup>1< / com:Sup> is independently selected from the group consisting of hydrogen, sodium, potassium, lithium, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycle, substituted or unsubstituted amino, thiamine (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), pyridoxine (vitamin B6), <com:Math><semantics>−N(RA)−CO2RC<annotation encoding="application / x-tex">-N(R^A)-CO_2R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(RA)−CO2RB<annotation encoding="application / x-tex">-N(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, substituted heterocycle, and substituted amino are substituted with one to five substituents independently selected from the group consisting of –(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, -CN, -NO<com:Sub>2< / com:Sub>, -C(O)R<com:Sup>C< / com:Sup>, -C(O)OR<com:Sup>C< / com:Sup>, -C(O)NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>−OC(O)NR2C<annotation encoding="application / x-tex">-OC(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C<annotation encoding="application / x-tex">-NR^C_3< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR4C<annotation encoding="application / x-tex">-NR^C_4< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R1C<annotation encoding="application / x-tex">R^C_1< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR4C<annotation encoding="application / x-tex">-NR^C_4< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R2C<annotation encoding="application / x-tex">R^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR4C<annotation encoding="application / x-tex">-NR^C_4< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R2C<annotation encoding="application / x-tex">R^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR4C<annotation encoding="application / x-tex">-NR^C_4< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R4C<annotation encoding="application / x-tex">R^C_4< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R4C<annotation encoding="application / x-tex">R^C_4< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R4C<annotation encoding="application / x-tex">R^C_4< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R4C<annotation encoding="application / x-tex">R^C_4< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R4C<annotation encoding="application / x-tex">R^C_4< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R4C<annotation encoding="application / x-tex">R^C_4< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R4C<annotation encoding="application / x-tex">R^C_4< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R4C<annotation encoding="application / x-tex">R^C_4< / annotation>< / semantics>< / com:Math>C(O) <com:Math><semantics>−NRCSO2NR2C<annotation encoding="application / x-tex">-NR^{C}SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OSO2(C1−C6)<annotation encoding="application / x-tex">-OSO_{2}(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math> alkyl, <com:Math><semantics>−SO2NR2C<annotation encoding="application / x-tex">-SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0201] or, alternatively, Y<com:Sup>1< / com:Sup> and W<com:Sup>1< / com:Sup> taken together are selected from the group consisting of sodium, potassium, lithium, magnesium, calcium, strontium, barium, and substituted or unsubstituted 2-(methylenyl)phenyl; wherein the substituted 2-(methylenyl)phenyl is substituted with one to four substituents independently selected from the group consisting of <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OR3C<annotation encoding="application / x-tex">-OR^{C}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NR2C<annotation encoding="application / x-tex">-OC(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)alkylene−NR2C<annotation encoding="application / x-tex">-(C_1-C_6)alkylene-NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^{C}_{2}< / annotation>< / semantics>< / com:Math>C(O)R<com:Sup>C< / com:Sup>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^{C}_{2}< / annotation>< / semantics>< / com:Math>C(O)O(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -NR<com:Sup>C< / com:Sup>C(O)NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -NR<com:Sup>C< / com:Sup>SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -SR<com:Sup>C< / com:Sup>, -S(O)R<com:Sup>C< / com:Sup>, -SO<com:Sub>2< / com:Sub>R<com:Sup>C< / com:Sup>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0202] optionally wherein Y<com:Sup>3< / com:Sup> is oxygen, sulfur, or absent;
[0203] optionally wherein W<com:Sup>3< / com:Sup> is oxygen, sulfur, or absent;
[0204] each of <com:Math><semantics>Z1<annotation encoding="application / x-tex">Z^1< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>Z2<annotation encoding="application / x-tex">Z^2< / annotation>< / semantics>< / com:Math> is independently NH or oxygen;
[0205] each of <com:Math><semantics>Z3<annotation encoding="application / x-tex">Z^3< / annotation>< / semantics>< / com:Math> and <com:Math><semantics>Z5<annotation encoding="application / x-tex">Z^5< / annotation>< / semantics>< / com:Math> is independently nitrogen or oxygen;
[0206] m is 1 or 2;
[0207] n is 0 or 1;
[0208] q is 1 or 2;
[0209] R<com:Sup>1< / com:Sup> is selected from the group consisting of hydrogen, substituted or unsubstituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, and substituted or unsubstituted heterocycle, vitamin B1 ester, vitamin B2 ester, vitamin B6 ester, choline ester, biotin ester, vitamin A ester, pterostilbene ester, resveratrol ester, aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, <com:Math><semantics>−N(RA)−CO2RC<annotation encoding="application / x-tex">-N(R^A)-CO_2R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−N(RA)−CO2RB<annotation encoding="application / x-tex">-N(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, and substituted heterocycle are substituted with one to five substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^C)NR^C_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2C<annotation encoding="application / x-tex">-NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)R1C<annotation encoding="application / x-tex">-NR^{C}_{3}(O)R^{C}_{1}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{C}_{3}(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NR3C(O)NR2C<annotation encoding="application / x-tex">-NR^{C}_{3}(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR3C(O)NR2C<annotation encoding="application / x-tex">-NR^{C}_{3}(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SR3C<annotation encoding="application / x-tex">-SR^{C}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OSO2(C1−C6)<annotation encoding="application / x-tex">-OSO_{2}(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−SO2NR2C<annotation encoding="application / x-tex">-SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0210] wherein when <com:Math><semantics>R1<annotation encoding="application / x-tex">R^1< / annotation>< / semantics>< / com:Math> is hydrogen, <com:Math><semantics>Z2<annotation encoding="application / x-tex">Z^2< / annotation>< / semantics>< / com:Math> is oxygen, and n is 0, the compound or derivative having formula (III) may optionally take the form of the carboxylate anion conjugate base species of the compound or derivative having formula (III), further optionally associated with a positively charged counterion selected from the group consisting of calcium, magnesium, potassium, sodium, zinc, and ammonium cations;
[0211] R<com:Sup>A< / com:Sup> is selected from the group consisting of –H, –(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(CH<com:Sub>2< / com:Sub>)<com:Sub>3< / com:Sub>-NH-C(NH<com:Sub>2< / com:Sub>)(=NH), -CH<com:Sub>2< / com:Sub>C(=O)NH<com:Sub>2< / com:Sub>, -CH<com:Sub>2< / com:Sub>COOH, -CH<com:Sub>2< / com:Sub>SH, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>C(=O)-NH<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>COOH, -CH<com:Sub>2< / com:Sub>-(2-imidazolyl), -CH(CH<com:Sub>3< / com:Sub>)-CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>4< / com:Sub>-NH<com:Sub>2< / com:Sub>, -(CH<com:Sub>2< / com:Sub>)<com:Sub>2< / com:Sub>-S-CH<com:Sub>3< / com:Sub>, phenyl, -CH<com:Sub>2< / com:Sub>-phenyl, -CH<com:Sub>2< / com:Sub>-OH, -CH(OH)-CH<com:Sub>3< / com:Sub>, -CH<com:Sub>2< / com:Sub>-(3-indolyl), -CH<com:Sub>2< / com:Sub>-(4-hydroxyphenyl), -CH(CH<com:Sub>3< / com:Sub>)<com:Sub>2< / com:Sub>, -NH<com:Sub>2< / com:Sub>, and -CH<com:Sub>2< / com:Sub>-CH<com:Sub>3< / com:Sub>;
[0212] each R<com:Sup>B< / com:Sup> is independently hydrogen or –(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl;
[0213] each R<com:Sup>C< / com:Sup> is independently selected from the group consisting of hydrogen, -(C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted pyridyl, substituted or unsubstituted 1,4- dihydropyridyl, a radical of a compound or derivative having formula (I), and vitamin B7 ester (biotinyl); wherein the substituted pyridyl and substituted 1,4-dihydropyridyl are substituted with one to five substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, -CN, -NO<com:Sub>2< / com:Sub>, -C(O)R<com:Sup>B< / com:Sup>, -C(O)OR<com:Sup>B< / com:Sup>, <com:Math><semantics>−C(O)NR2B<annotation encoding="application / x-tex">-C(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRB)NR2B<annotation encoding="application / x-tex">-C(=NR^{B})NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OR3B<annotation encoding="application / x-tex">-OR^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NR2B<annotation encoding="application / x-tex">-OC(O)NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR2B<annotation encoding="application / x-tex">-NR^{B}_{2}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R3B<annotation encoding="application / x-tex">R^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR4B<annotation encoding="application / x-tex">-NR^{B}_{4}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R3B<annotation encoding="application / x-tex">R^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR4B<annotation encoding="application / x-tex">-NR^{B}_{4}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R3B<annotation encoding="application / x-tex">R^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR4B<annotation encoding="application / x-tex">-NR^{B}_{4}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R3B<annotation encoding="application / x-tex">R^{B}_{3}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NR4B<annotation encoding="application / x-tex">-NR^{B}_{4}< / annotation>< / semantics>< / com:Math>C(O)<com:Math><semantics>R3B<annotation encoding="application / x-tex">R^{B}_{3}< / annotation>< / semantics>< / com:Math> -NR<com:Sup>B< / com:Sup>C(O)NR<com:Sup>B< / com:Sup><com:Sub>2< / com:Sub>, -NR<com:Sup>B< / com:Sup>SO<com:Sub>2< / com:Sub>NR<com:Sup>B< / com:Sup><com:Sub>2< / com:Sub>, -SR<com:Sup>B< / com:Sup>, -S(O)R<com:Sup>B< / com:Sup>, -SO<com:Sub>2< / com:Sub>R<com:Sup>B< / com:Sup>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>B< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>B< / com:Sup>;
[0214] R<com:Sup>2< / com:Sup>, R<com:Sup>3< / com:Sup>, R<com:Sup>4< / com:Sup>, and R<com:Sup>5< / com:Sup> are each independently selected from the group consisting of hydrogen, –(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, –(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, –(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, –CN, –NO<com:Sub>2< / com:Sub>, –C(O)R<com:Sup>C< / com:Sup>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)alkyl<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_1-C_6)alkyl< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCC(O)NRC2<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NRC2<annotation encoding="application / x-tex">-NR^{C}SO_2NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_2R^{C}< / annotation>< / semantics>< / com:Math>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0215] R<com:Sup>7< / com:Sup> and R<com:Sup>8< / com:Sup> are independently selected from the group consisting of hydrogen, -C(O)R', -C(O)OR', -C(O)NHR', substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycle, substituted or unsubstituted aryl(C<com:Sub>1< / com:Sub>- C<com:Sub>4< / com:Sub>)alkyl, and substituted or unsubstituted heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, substituted heterocycle, substituted aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, and substituted heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl are substituted with one to five substituents independently selected from the group consisting of <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkenyl, <com:Math><semantics>−(C2−C6)<annotation encoding="application / x-tex">-(C_2-C_6)< / annotation>< / semantics>< / com:Math>alkynyl, halogen, <com:Math><semantics>−CN<annotation encoding="application / x-tex">-CN< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NO2<annotation encoding="application / x-tex">-NO_2< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^C< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NRC<annotation encoding="application / x-tex">-C(O)NR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NRC<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)alkyl<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_1-C_6)alkyl< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCC(O)NRC2<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NRC2<annotation encoding="application / x-tex">-NR^{C}SO_2NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_2R^{C}< / annotation>< / semantics>< / com:Math>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0216] R' is selected from the group consisting of hydrogen, substituted or unsubstituted (C<com:Sub>1< / com:Sub>- C<com:Sub>8< / com:Sub>)alkyl, substituted or unsubstituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycle, vitamin B1 ester, vitamin B2 ester, vitamin B6 ester, choline ester, biotin ester, vitamin A ester, resveratrol ester, aryl(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, heterocycle(C<com:Sub>1< / com:Sub>-C<com:Sub>4< / com:Sub>)alkyl, –N(R<com:Sup>A< / com:Sup>)–CO<com:Sub>2< / com:Sub>R<com:Sup>C< / com:Sup>, –N(R<com:Sup>A< / com:Sup>)–CO<com:Sub>2< / com:Sub>R<com:Sup>B< / com:Sup>, <com:Math><semantics>−C**H−(RA)−NH2<annotation encoding="application / x-tex">-C^{**}H-(R^A)-NH_2< / annotation>< / semantics>< / com:Math>, and <com:Math><semantics>−C**H−(RA)−CO2RB<annotation encoding="application / x-tex">-C^{**}H-(R^A)-CO_2R^B< / annotation>< / semantics>< / com:Math>; wherein the substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)alkyl, substituted (C<com:Sub>1< / com:Sub>-C<com:Sub>8< / com:Sub>)cycloalkyl, substituted aryl, substituted heteroaryl, and substituted heterocycle are substituted with one to five substituents independently selected from the group consisting of -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkenyl, -(C<com:Sub>2< / com:Sub>-C<com:Sub>6< / com:Sub>)alkynyl, halogen, -CN, -NO<com:Sub>2< / com:Sub>, <com:Math><semantics>−C(O)RC<annotation encoding="application / x-tex">-C(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)ORC<annotation encoding="application / x-tex">-C(O)OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(O)NR2C<annotation encoding="application / x-tex">-C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−C(=NRC)NR2C<annotation encoding="application / x-tex">-C(=NR^{C})NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−ORC<annotation encoding="application / x-tex">-OR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−OC(O)(C1−C6)<annotation encoding="application / x-tex">-OC(O)(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)O(C1−C6)<annotation encoding="application / x-tex">-OC(O)O(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−OC(O)NRC2<annotation encoding="application / x-tex">-OC(O)NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−(C1−C6)<annotation encoding="application / x-tex">-(C_1-C_6)< / annotation>< / semantics>< / com:Math>alkylene<com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRC2<annotation encoding="application / x-tex">-NR^{C_2}< / annotation>< / semantics>< / com:Math> <com:Math><semantics>−NRCC(O)O(C1−C6)<annotation encoding="application / x-tex">-NR^{C}C(O)O(C_{1}-C_{6})< / annotation>< / semantics>< / com:Math>alkyl, <com:Math><semantics>−NRCC(O)NR2C<annotation encoding="application / x-tex">-NR^{C}C(O)NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−NRCSO2NR2C<annotation encoding="application / x-tex">-NR^{C}SO_{2}NR^{C}_{2}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SRC<annotation encoding="application / x-tex">-SR^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−S(O)RC<annotation encoding="application / x-tex">-S(O)R^{C}< / annotation>< / semantics>< / com:Math>, <com:Math><semantics>−SO2RC<annotation encoding="application / x-tex">-SO_{2}R^{C}< / annotation>< / semantics>< / com:Math>, -OSO<com:Sub>2< / com:Sub>(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkyl, -SO<com:Sub>2< / com:Sub>NR<com:Sup>C< / com:Sup><com:Sub>2< / com:Sub>, -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)perfluoroalkyl, and -(C<com:Sub>1< / com:Sub>-C<com:Sub>6< / com:Sub>)alkylene-OR<com:Sup>C< / com:Sup>;
[0217] R<com:Sup>9< / com:Sup> and R<com:Sup>10< / com:Sup> are independently selected from the group consisting of hydrogen, -C(O)R', -C(O)OR', -C(O)NHR', substi...
Claims
1. A crystalline Form I of nicotinic acid riboside (NAR) according to formula (VIII): [Image disponible dans le document PDF, Image available in the PDF document] (VIII) that is characterized by a powder X-ray diffraction pattern having peaks at 19.2, 21.6, and2. The crystalline Form I according to claim 1 that is characterized by a powder X- ray diffraction pattern having peaks at 15.7, 19.2, 21.6, 26.4, and 28.9 degrees two theta±0.2 degrees two theta.
3. The crystalline Form I according to claim 1 that is characterized by a powder X- ray diffraction pattern having peaks as shown in FIG. 17.
4. The crystalline Form I according to claim 1 that is prepared by a method comprising the steps of: (a) dissolving the compound having formula (VIII), or a salt or solvate thereof, in a volume of methanol; (b) adding a volume of acetone, of an equal volume to the volume of methanol, to the compound having formula (VIII), or salt or solvate thereof, in the volume of methanol; (c) precipitating the crystalline Form I; and (d) isolating the crystalline Form I.
5. The crystalline Form I according to claim 4 that is prepared by a method further comprising the steps of: (a1) providing a compound having formula (1a), or a salt thereof: [Image disponible dans le document PDF, Image available in the PDF document] (1a) wherein Z 2 Z^2 is oxygen; n is 0; R 1 is hydrogen, or a carboxylate anion conjugate base species selected from the group consisting of calcium, magnesium, potassium, sodium, zinc, and ammonium cations; each of R 2 , R 3 , R 4 , and R 5 is hydrogen; (a2) treating the compound having formula (1a), or salt thereof, with excess trimethylsilylating reagent(s) so as to produce a compound having formula (1a), or salt thereof, wherein R 1 is a TMS group; (a3) removing the trimethylsilylating reagent(s); (a4) treating the compound having formula (1a), or salt thereof, wherein R 1 is a TMS group, with a molar equivalent amount of a compound having formula (2), or a salt thereof, and a molar equivalent amount of TMSOTf, in an organic solvent: [Image disponible dans le document PDF, Image available in the PDF document] (2) wherein X' is selected from the group consisting of fluoro, chloro, bromo, iodo, HCO 2 , acetoxy, propionoxy, butyroxy, glutamyloxy, aspartyloxy, ascorbyloxy, benzoxy, HOCO 2 , citryloxy, carbamyloxy, gluconyloxy, lactyloxy, succinyloxy, sulfoxy, trifluoromethanesulfoxy, trichloromethanesulfoxy, tribromomethanesulfoxy, and trifluoroacetoxy; each of R 6 R^6 , R 7 R^7 , and R 8 R^8 is − C ( O ) R ′ -C(O)R' ; R' is methyl; (a5) processing the compound having formula (1a), or salt thereof, wherein R 1 is a TMS group, the compound having formula (2), or salt thereof, the TMSOTf, and the organic solvent so as to produce a compound having formula (Ia), or salt or solvate thereof, wherein R 1 is a TMS group; [Image disponible dans le document PDF, Image available in the PDF document] (Ia) wherein X- is selected from the group consisting of fluoride, chloride, bromide, iodide, formate, acetate, propionate, butyrate, glutamate, aspartate, ascorbate, benzoate, carbonate, citrate, carbamate, gluconate, lactate, succinate, sulfonate, trifluoromethanesulfonate, trichloromethanesulfonate, tribromomethanesulfonate, and trifluoroacetate; and Z 2 Z^2 , n, R 2 R^2 , R 3 R^3 , R 4 R^4 , R 5 R^5 , R 6 R^6 , R 7 R^7 , R 8 R^8 and R ′ R' as defined above; (a6) isolating the compound having formula (Ia), or salt or solvate thereof; (a7) dissolving the compound having formula (Ia), or salt or solvate thereof, in methanol, in a gas pressure tube; (a8) cooling the solution of the compound having formula (Ia), or salt or solvate thereof, in methanol, to − 78 ∘ -78^{\circ} C; (a9) bubbling ammonia gas into the solution of the compound having formula (Ia), or salt or solvate thereof, in methanol; (a10) sealing the pressure tube; (a11) raising the temperature to − 20 ∘ -20^{\circ} C; (a12) cooling the pressure tube at − 20 ∘ -20^{\circ} C for about 12 hours to about 4 days, so as to produce the compound having formula (VIII), or salt or solvate thereof; (a13) unsealing the gas pressure tube; and (a14) isolating the compound having formula (VIII), or salt or solvate thereof; wherein the steps (a1) to (a15) are performed sequentially, before step (a).
6. The crystalline Form I according to claim 5, wherein the processing of step (a5) is selected from the group consisting of batch processing, liquid-assisted mixing, milling, grinding, and extruding.
7. A crystalline Form I of nicotinic acid riboside triacetate (NARTA) according to formula (X): [Image disponible dans le document PDF, Image available in the PDF document] (X) •8. The crystalline Form I of claim 7 that is characterized by a powder X-ray diffraction pattern having peaks at 4.7, 9.5, and 20.5 degrees two theta±0.2 degrees two theta.
9. The crystalline Form I of claim 7 that is characterized by a powder X-ray diffraction pattern having peaks at 4.7, 9.5, 16.5, 16.8, and 20.5 degrees two theta±0.2 degrees two theta.
10. The crystalline Form I of claim 7 that is characterized by a powder X-ray diffraction pattern having peaks at 4.7, 9.5, 12.0, 16.5, 16.8, 19.9, 20.5, 23.7, and 23.9 degrees two theta±0.2 degrees two theta.
11. The crystalline Form I of claim 7 that is characterized by a powder X-ray diffraction pattern as shown in FIG. 19.
12. The crystalline Form I of claim 7 that is characterized by an IR spectrum having peaks at 603.6, 684.6, 763.7, and 781.0 cm -1±0.2 cm -1 .
13. The crystalline Form I of claim 7 that is characterized by an IR spectrum having peaks at 603.6, 684.6, 763.7, 781.0, 858.2, 894.8, 921.8, 1026.0, 1051.0, and 1066.5 cm -1±0.2 c m − 1 cm-1 .
14. The crystalline Form I of claim 7 that is characterized by an IR spectrum having peaks at 603.6, 684.6, 763.7, 781.0, 858.2, 894.8, 921.8, 1026.0, 1051.0, 1066.5, 1610.3, 1639.2, and 1743.4 cm − 1 ± 0.2 cm − 1 1743.4 \text{ cm} - 1 \pm 0.2 \text{ cm} - 1 .
15. The crystalline Form I of claim 7 that is characterized by an IR spectrum as shown in FIG. 25.
16. The crystalline Form I of claim 7 that is characterized by a DSC thermogram as shown in FIG. 33.
17. The crystalline Form I of claim 7 that is characterized by a DSC thermogram obtained using a heating rate of 10 K / min comprising an endothermic event with an onset temperature of 148° C±2° C.
18. The crystalline Form I of claim 7 that is characterized by a DSC thermogram obtained using a heating rate of 10 K / min comprising an endothermic event with a peak temperature of 152° C±2° C.
19. The crystalline Form I of claim 7 that is characterized by a DSC thermogram obtained using a heating rate of 10 K / min comprising an endothermic event with an onset temperature of 148° C±2° C and a peak temperature of 152° C±2° C.
20. The crystalline Form I of claim 7 that is prepared by a method comprising the steps of: (a) dissolving the compound having formula (X), or salt or solvate thereof, in a volume of methanol; (b) adding a volume of acetone, of an equal volume to the volume of methanol, to the compound having formula (X), or salt or solvate thereof, in the volume of methanol; (c) precipitating the crystalline Form I; and (d) isolating the crystalline Form I.
21. The crystalline Form I of claim 20 that is prepared by a method further comprising the steps of: (a1) providing a compound having formula (1a), or a salt thereof: [Image disponible dans le document PDF, Image available in the PDF document] (1a) wherein Z2 is oxygen; n is 0; R1 is hydrogen; wherein the compound having formula (1a) may optionally take the form of the carboxylate anion conjugate base species of the compound having formula (Ia), further optionally associated with a positively charged counterion selected from the group consisting of calcium, magnesium, potassium, sodium, zinc, and ammonium cations; each of R2, R3, R4, and R5 is hydrogen; (a2) treating the compound having formula (1a), or salt thereof, with excess trimethylsilylating reagent(s) so as to produce a compound having formula (Ia), or salt thereof, wherein R1 is a TMS group; (a3) removing the trimethylsilylating reagent(s); (a4) treating the compound having formula (1a), or salt thereof, wherein R1 is a TMS group, with a molar equivalent amount of a compound having formula (2), or a salt thereof: [Image disponible dans le document PDF, Image available in the PDF document] (2) wherein X' is selected from the group consisting of fluoro, chloro, bromo, iodo, HCO2, acetoxy, propionoxy, butyroxy, glutamyloxy, aspartyloxy, ascorbyloxy, benzoxy, HOCO2, citryloxy, carbamyloxy, gluconyloxy, lactyloxy, succinyloxy, sulfoxy, trifluoromethanesulfoxy, trichloromethanesulfoxy, tribromomethanesulfoxy, and trifluoroacetoxy; each of R6, R7, and R8 is C ( O ) R ′ C(O)R' ; R' is methyl; and a molar equivalent of a Lewis acid, in an organic solvent; (a5) processing the compound having formula (1a), or salt thereof, wherein R1 is a TMS group, the compound having formula (2), or salt thereof, the Lewis acid, and the organic solvent so as to produce the compound having formula (Ia), or salt or solvate thereof, wherein R1 is a TMS group; [Image disponible dans le document PDF, Image available in the PDF document] (Ia) wherein X- is selected from the group consisting of fluoride, chloride, bromide, iodide, formate, acetate, propionate, butyrate, glutamate, aspartate, ascorbate, benzoate, carbonate, citrate, carbamate, gluconate, lactate, succinate, sulfonate, trifluoromethanesulfonate, trichloromethanesulfonate, tribromomethanesulfonate, and trifluoroacetate; and Z2, n, R2, R3, R4, R5, R6, R7, R8 and R' as defined above; (a6) adjusting the pH of the aqueous phase; (a7) separating the organic phase from the aqueous phase; (a8) freeze-drying the aqueous phase to provide the compound having formula (X), or salt or solvate thereof; wherein the steps (a1) to (a9) are performed sequentially, before step (a).
22. The crystalline Form I of claim 21, wherein the processing of step (a5) is selected from the group consisting of batch processing, liquid-assisted mixing, milling, grinding, and extruding.
